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Pyridoxal-5-phosphate (PLP) , the biologically active form of 
vitamin B-6, acts as a cofactor for enzymes catalysing 
transaminase, decarboxylase and synthetase reactions (among 
others) in pathways spanning carbohydrate metabol ism 
spingolipid biosynthesis and degradation, amino acid 
metabolism, hemoglobin biosynthesis, neurotransmitter 
biosynthesis, and in other pathways for many other important 
biomolecules (Merrill and Henderson, 1987). The metabolic 
participation of vitamin B-6 represents a versatility 
probably not matched by any other coenzyme. Over one hundred 
enzymes are known to require PLP as an activating coenzyme 
(Sauberlich, 1985). Thus, in view of its important role in 
intermediate metabolism and diversity of function an 
increasing interest has arisen in this field. 
Trace elements, such as copper, iron and zinc act as 
catalysts in a wide range of enzyme systems, either through 
substrate activation or in the form of metalloenzymes. 
Consequently it is not unexpected that diverse interactions 
exist between vitamin B-6 and trace elements. 
1 
Few studies have been conducted to investigate the link 
between vitamin B-6 deficiency and trace element status. 
Hsu, 1965 reported a decrease in zinc content of plasma, 
liver, pancreas and heart of vitamin B-6 deficient rats. 
contrary to these findings, Gershoff, 1968 found an increase 
in the zinc levels of the rat pancreas and kidney. Prasad 
et aI, 1982 attributed this increase to a direct effect of 
vitamin B-6 on the intestinal mucosa. They suggested that 
pyridoxine deficiency may result in impairment of nucleic 
acid synthesis with consequent inhibition of protein 
synthesis. Thus it is probable that an alteration in the 
brush border membrane will lead to non-specific metal-ion 
uptake. It is also known that picolinic acid facilitates 
zinc absorption. PLP is required for picol inic acid 
formation. Thus a deficiency of vitamin B-6 may impair zinc 
absorption (Evans and Johnson, 1980). 
Pyridoxine deficiency has also been reported to have led to 
an elevation of Fe stores in the liver and kidney (Kirksey 
and Tabacchi, 1967, Ikeda et aI, 1979). Increased liver 
stores have been attributed to that fact that less Fe is 
incorporated into hemoglobin in pyridoxine deficiency since 
PLP is involved in hemoglobin synthesis. 
2 
Copper is needed for iron mobilization (Peereboom, 1985) and 
is mutually antagonistic to zinc. The close biological 
interaction of copper with zinc and iron and the fact that 
several copper metalloenzymes such as amine oxidases (Gray 
and Daniel, 1981) require PLP also warrants an investigation 
of the effect of vitamin B-6 on copper status. 
Thus, due to the lack of information and controversy 
surrounding the effect of vitamin B-6 on trace element 
status it seems necessary to investigate this issue further. 
Due to the importance of Cu, Fe and Zn as essential trace 
elements and because of their close biological interaction 
they were chosen for analysis. 
The dietary intake of copper, iron and zinc are reflected in 
tissue content (Delves, 1985, Jackson et aI, 1982). 
Therefore tissue content was chosen as a method for 
assessing trace element status. Due to the central role of 
the liver in trace element metabolism, it was selected for 
analysis. Because of their relatively high concentrations 
of eu, Fe and Zn, skeletal muscle, kidney and heart were 
also chosen for study (Prasad, 1978). 
The results of a balance study conducted by Channa, 1988 in 
our laboratories supported the idea of a possible link 
3 
between vitamin B-6 and trace elements. This type of study 
is important in that it provided an insight into the effect 
of vitamin B-6 on retention and excretion of trace elements 
(Beisel, 1979). Due to the limitations of this kind of 
assessment, however no information on body distribution of 
trace elements can be given. Therefore it was decided that 
the assessment of trace element status by measurement of 
tissue content be investigated. 
since it was found in the first study that the food intake 
of deficient rats was decreased, a second study was 
conducted including a pair-fed control group. Hence, a 
second study was conducted to distinguish between metabolic 
consequences arising solely from decreased food consumption 
and those related directly to vitamin B-6. 
Thus the major objectives of this study were: 
1) To induce varying levels of vitamin B-6 deficiency 
states in the rats. 
2) To compare the food intake between the various groups of 
deficient and control rats and pair-feed the deficient 
group. 
3) To compare the growth rate between all groups. 
4) To assess trace element status by determining the levels of 




2.1 Historical background of vitamin B-6 
In 1926, Goldberger and Lillie fed rats a diet deficient in 
what was considered to be a pellagra-preventitive factor; 
these animals developed dermatitis acrodynia. Gyorgy, in 
1934, observed that this same factor prevented development 
of skin lesions in the rat. He was the first to demonstrate 
that besides vitamin B-1, and B-2, the vitamin B-complex 
contained a third factor which was named vitamin B-6 (See 
Labadarios and Shephard, 1984). 
vitamin B-6 was isolated in 1938 by three research groups 
working independantly and was synthesized by Harris and 
Folkers in 1939. Two other natural forms of the vitamin, 
pyridoxal and pyridoxamine, were shown to exist in 1945 
(Driskell, 1984). 
2.2 Nomenclature 
vitamin B-6 is a collective term for three naturally 
occurring related compounds: pyridoxine (PN) , pyridoxal 
5 
(PL) and pyridoxamine (PM). It is recommended as the 
generic descriptor for all 3-hydroxy-2-methylpyridine 
derivatives that exhibit the biological activity of 
pyridoxine in rats (Rutishauser, 1982). 
2.3 Chemistry of vitamin B-6 
The three naturally occurring forms of vitamin B-6 are 
pyridoxine, pyridoxal or pyridoxamine. In animal products, 
pyridoxal and pyridoxamine predominate while in plant 
products pyridoxine predominates (Driskell, 1984). 
The different forms of vitamin B-6 may be characterized 
structurally as displayed in Figure 1: 




RI = H R = CH20H Pyridoxine (PN) 
RI = H R = CHO Pyridoxal (PL) 
RI = H R CH2NH2 pyridoxamine (PM) 
RI = PO 2- R CH20H Pyridoxine-5
1
- phosphate (PNP) 
3 
RI = PO 2- R = CHO Pyridoxal -5 1 - phospate (PLP) 3 
RI = PO 2- R = CH2NH2 pyridoxamine-5
1 - phosphate (PMP) 
3 
FIG 1. The chemical structure of vitamin B-6 vitamers. 
All forms of the vitamin are readily soluble in water and 
are slightly soluble in ethanol and insoluble in ether. 
Aqueous solutions of the vitamin are unstable in visible and 
UV light and are destroyed by heating. Researchers working 
with this nutrient thus perform their analysis in darkened 
laboratories (Driskell, 1984). Pyridoxine and pyridoxamine 
are stable in hot dilute mineral acids and alkalis, while 
pyridoxal decomposes in hot dilute alkali (Labadarios and 
Shephard, 1984). 
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All forms of the vitamin occur as white crystals. Pyridoxine 
hydrochloride (PN.HCl) is the commonly available synthetic 
form of the vitamin. It is easily crystallizable and 
odorless and has a molecular weight of 205.6 and a melting 
point of 206°C. This form of the vitamin is typically used 
in nutrient supplements and animal diets. Pyridoxine 
hydrochloride is used by pharmaceutical companies in drug 
preparation. A 10% loss of vitamin activity was found in 
several pharmaceutical products after storage for 1 year at 
23°C (Driskell, 1984). 
2.4 Total Body Content of vitamin B-6 in Man 
In adult men and women the total body stores of vitamin B-6 
have been estimated to be between 20 to 150mg of PN. A 
large share of body vitamin B-6 is contained in 
phosphorylase and in muscle most vitamin B-6 is contained in 
this enzyme. The total blood content of vitamin B-6 is 
about 0,5mg PN (Rutishauser, 1982). 
2.5 Physiological Functions of vitamins B-6 
PLP, the active form of vitamin B-6, serves as a coenzyme in 
several metabolic reactions. The functions of vitamin B-6 
will be reviewed from the perspective of the role of PLP. 
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The role of PLP can be viewed from a biochemical and a 
cellular viewpoint (Leklem, 1988). wi th respect to its 
biochemical function, pyridoxal-5-phosphate forms a Schiff's 
base with amino acids and other nitrogen containing 
compounds. 
The functions of vitamin B-6 from a systems or cellular 
point of view are depicted in Figure 2 (Leklem, 1988). Most 
of the cellular processes affected by PLP are related to the 
role of PLP in amino-acid metabolism (Leklem, 1988). 
Reactions wilh other lysine (Schiff Base) 
P'''';"'-~ / LCHO'mO"' mOd"'oIIO") 
"Vitamin 9-6" PLP GI -------... _ ycogen -(Gluconeogenesis) 
PH, Pl, PM :XPhOSPhorYlase / 
1 "r"",,ml",lIo" ----, 
/;-A-m-j n-o-A-c id Hem e 
Sullur Arno Acids ~.-----/ Metabolism Binding -.... 02 af\,lty 
Protein ~MethYla'Ae Heme ,,:--!.----., 
Carnitine Synthesis 
~ 
Synthesis --_. RBC function 
l -Carbon Metabolism 
~ 





+ Zinc absorption? 
FIG. 2 Cellular processes in which PLP acts as a coenzyrne 
or binds with proteins and modifies the action of the 
protein. 
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2.5.1 Role of PLP in Transamination reactions 
All known aminotransferases are PLP dependent. Most amino 
acids at some stage of their metabolism undergo 
transamination except for threonine, lysine, proline and 
hydroxyproline (Sauberlich, 1985). Transamination involves 
the interconversions of a pair of amino acids into their 
corresponding keto acids. In the initial step a PLP-enzyme 
complex is formed. The bound PLP undergoes a reaction with 
an amino acid to form a keto acid and enzyme bound PMP. 
(Fig. 3) (Labadarios and Shephard, 1984) 
I-alanine pyridoxal I-glutamate 
pyruvate pyridoxamine a-ketoglutarate 
FIG. 3 Role of vitamin B-6 in transamination reactions. 
This general reaction permits catabolism, interconversion 
and synthesis of amino acids and a-ketoglutarate is more 
often the acceptor of the amino group. As a result of this 
10 
reaction amino acids such as alanine and serine are 
synthesized (Sauberlich, 1985). 
2.5.2 GABA Synthesis 
vitamin B-6 is needed in the brain for the decarboxylation 
of glutamic acid to Y -aminobutyric acid (GABA) (Diskell, 
1984) L-Glutamic acid decarboxylase 1, found in the brain 
is a PLP-dependent enzyme catalysing the formation of GABA 












FIG.4 : Role of vitamin B-6 in GABA synthesis. 
GABA is required as a normal regulator of neuronal activity 
and has an inhibiting effect on the central nervous system 
(eNS). Decreased levels of PLP may result in suppression of 
glutamate decarboxylase activity resulting in lower GABA 
11 
concentrations. This results in convulsions which can be 
corrected by vitamin B-6 administration (Labadarios and 
Shephard, 1984). 
2.5.3 serotonin Synthesis 
Serotonin (5-Hydroxytryptamine) is produced by the action 
tryptophan decarboxylase on 5-hydroxytrytophan as 





1. Serotonln (5-hydroxytryptamine) 
PLP (Tryptophan decarboxylose) 
FIG. 5 : Role of vitamin B-6 in serotonin synthesis. 
Serotonin is a potent vasoconstrictor and a stimulator of 
smooth muscle contraction and also functions in the same 
manner in the brain (Driskell, 1984). 
2.5.4 catecholamine Synthesis 
PLP dependent enzymes are involved in the synthesis of 
catecholamine hormones viz., dopamine, norepinephrin and 






1 Tyrosine hydroxylase 
Dihydroxyphenylalanine (DOPA) 
1 (DOPA decarboxylase) 
- Dihydroxyphenyl ethylamine (Dopamine) 
(02 + ascorbic acid) 1 (Dopamine ~-oxidase) 
Norepinephrin 
(S-adenosyl methionine) 1 (Phenyl ethanol amine N-methyl transferase) 
Epinephrin 
FIG. 6 The role of vitamin B-6 in catecholamine synthesis 
The decarboxylase activity is increased in vitro by the 
addition of PLP and in vivo by the elevation of tissue PLP 
levels. Dopamine levels were reported to be elevated by 
pyridoxine adminstration (Labadarios and Shephard, 1984). 
2.5.5 Polyamine Synthesis 
Ornithine is decarboxylated by the PLP dependent enzyme, 
ornithine decarboxylase to form putrescine. Putrescine 
serves as a precursor for the polyamines, spermine and 
spermidine. orni thine may also be reacted upon by 
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ornithine-cS-transaminase which is PLP dependent to form 
glutamic acid semialdehyde. This may serve as a precursor 
for proline. Hyperornithemia, caused by a genetic defect in 
ornithine decarboxylase which gives rise to elevated 
orni thine in plasma may result in gyrate atrophy and 
impaired visual functions. vitamin B-6 supplements have 
been encourgaging in stabilizing of visual functions 
(Sauberlich, 1985). 
2.5.6 vitamin B-6 and sulphur amino acids 
Sulphur containing 
numerous pathways 
Shephard, 1984) . 
shown in Figure 7. 
amino acids are metabolized through 
which require PLP (Labadarios and 
The pathway for methionine metabolism is 
Methionine and cysteine are important in protein 
biosynthesis. Cysteine is involved in maintaining protein 
configuration through disulphide bond formation (Tryfiates, 
1986). Taurine is an essential amino acid in man (Sturman, 
1981) . The enzymes involved in Figure 7 are affected by 
vitamin B-6 deficiency but not to the same extent. 
Nutritional vitamin B-6 deficiency has little effect on 
cystathionine synthase deficiency because of the tight bond 
between PLP and this enzyme. Homocystinuria due to 
14 
cystathionine synthase def iciency is inherited. The 
symptoms include optic lens dislocation, progressive 
skeletal deformities and severe thrombo-embol ic disease. 
Biochemically it is characterized by high concentrations of 
homocysteine and methionine and abnormally low 
concentrations of plasma and urine cysteine (Labadarios and 
Shephard, 1984). 
Vitamin B-6 is not tightly bound to apocystathionase or 
apocysteinesulphinic decarboxylase. A deficiency of vitamin 
B-6 causes a reduction in holocystathionase and 
cystathionuria which is reversed by pyridoxine supplements. 
Holocysteinesulphinic acid decarboxylase is reduced to zero 
during a vitamin B-6 deficiency but this has no biological 
significance because of the dietary intake of taurine 







PLP 1 Cystathionine synthase 
Cystathionine 













Role of vitamin B-6 in methionine metabolism 
Tryptophan metabolism 
vitamin B-6 and tryptophan-niacin metabolism is one of the 
most extensive vitamin B-6 amino acid interrelationships as 

























































































































































































































































































































































































































































































































































































































































































































This is partly related to the use of the tryptophan load 
test to assess vitamin B-6 status (Leklem, 1988). The key 
enzymes involved in tryptophan metabolism that require PLP 
are shown in Figure 8 (Brown, 1981). 
Kynureninase, a PLP dependent enzyme is very sensitive to a 
vitamin B-6 deficiency. I f this enzyme is impaired an 
increased excretion of tryptophan metabolites in the urine 
is observed. The metabolites in particular are xanthurenic 
acid, kynurenic acid, kynurenine and 3-hydroxyanthranilic 
acid. Some of these metabol i tes possess carcinogenic 
properties and may induce bladder tumors. 
The importance of the contribution of tryptophan metabolism 
to niacin needs has been recognised in diseases where the 
absorption and retention of tryptophan may result in a 
pellagra syndrome that responds to nicotinamide therapy 
(Sauberlich, 1985). 
It was reported that low vitamin B-6 intake may have only a 
moderate effect on the tryptophan to niacin conversion 
( Lekl em, 1988). 
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2.5.8 Role of vitamin B-6 in gluconeogenesis and 
glycogenolysis 
since PLP is a coenzyme for alanine aminotransferase, at 
cellular levels, PLP would be expected to influence the 
conversion of alanine to pyruvate. It has been demonstrated 
that under short-term fasting conditions, vitamin B-6 
deficiency has not compromised gluconeogenesis to an extent 
to which glucose synthesis is affected (Leklem, 1988). 
Subclinical vitamin B-6 deficiency has in some cases been 
associated with impaired glucose tolerance tests. This may 
be explained by the role of PLP in phosphorylase activity. 
Epinephrin, which is dependent on PLP for synthesis, 
stimultes phosphorolysis of glycogen. However, vitamin B-6 
may have an effect on insulin metabolism (Sauberlich, 1988). 
Glycogen phosphorylase, which catalyses the first step in 
glycogenolysis, contains PLP. The active form contains 4 
mol PLP while the inactive form, 2 mol PLP. PLP appears not 
to act as a coenzyme for the enzyme but rather to affect its 
conformation (Driskell, 1984). Studies carried out by 
certain investigators indicate that PLP associated with 
muscle glycogen phosphorylase may serve as a source for 
19 
vitamin B-6 during caloric deficit. The mechanism for PLP 
release has not been explained (Leklem, 1988). 
2.5.9 vitamin B-6 and erythrocyte function 
6-aminolevulinate synthase requires PLP for the synthesis of 
6-aminolevulinic acid (ALA). It is then acted upon by ALA 
dehydratase,a Zn containing enzyme to form porphobilinogen 
which is converted to heme (Fig. 9). Heme is incorporated 
during the formation of hemoglobin, myoglobin cyctochrome c, 
and other proteins requiring heme. (Sauberlich, 1985) 
20 
PLP 
Glycine + succinyl-CoA ----7 Schiff Base + 
1 
succinyl - CoA 









ConverS1on to Heme 
FIG. 9 The role of vitamin B-6 in heme synthesis. 
PLP and PL bind to hemoglobin (Hb) and erythrocyte 
aminotransferases. PL and PLP have different binding 
sites on Hb. While PLP lowers the 02 binding affinity of 
Hb, PL has the opposite effect. 
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2.5.10 vitamin B-6 and nucleic acid synthesis 
The involvement of vitamin B-6 in nucleic acid synthesis is 
depicted in Fig. 10 (Labadarios and Shephard, 1984) 
Deoxyuridine DNA Thymine 
t T 








~ DihyirOfolate reductase 
THFJ 
T Methionine 
5-Methyl THFA ( 
vitamin B-6 
Homocysteine 
FIG. 10 The involvement of vitamin B-6 in nucleic acid 
synthesis 
Glycine is synthesized from serine in a step that requires 
PLP. The methylene group N10 methylenetetra-
hydrofolate (methylene THFA) is the source of the methyl 
group for the synthesis of methionine and deoxythymidylate 
a key precursor for DNA synthesis (Tryfiates, 1986). 
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It has been concluded that a lack of vitamin B-6 impairs 
nucleic acid synthesis and results in a deleterious effect 
on protein production, cell division and repair. This 
impairment of nucleic acid synthesis is due to decreased c-1 
fragment production from serine that is needed for DNA and 
RNA biosynthesis (Tryfiates, 1986). 
PLP was also shown to inactivate certain tRNA synthetases, 
thus losing their ability to esterify amino acids to tRNA. 
It was also shown to modify tRNA causing it to lose the 
ability to accept amino acids and recognise mRNA codons. 
(Tryfiates, 1986) 
2.5.11 Lipids 
It was shown that vitamin B-6 deficiency in animals resulted 
in lower lipid content than controls. The symptoms of the 
deficiency include fatty liver, dermatitis, atherosclerosis 
and elevated plasma lipids (Driskell, 1984). The mechanism 
of vitamin B-6 involvement in lipid mtabolism has not been 
established. It is possible that the involvement of vitimin 
B-6 in lipid metabolism may represent the results of a 
secondary effects (Sauberlich, 1985). Driskell, 1984 
states that the effects on lipids may be via its effects on 
hormones. 
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Pyridoxine may function in the utilization of unsaturated 
fatty acids. Studies using Aspergillus nidulans, a 
pyridoxine-less mutant, suggested a possible involvement of 
pyridoxine in fatty acid chain elongation and in the 
desaturation of fatty acids (Sauberlich, 1985). 
2.5.12 steriod function 
The interaction of PLP with steroid function has recently 
been identified. Several studies have shown that PLP can be 
used to extract steroid receptors from nuclei (Leklem, 
1988) . 
PLP binds to DNA binding domains and prevents interaction of 
steroid receptors with DNA (Litwak et aI, 1985). Figure 11 
shows the functional groups of the glucocorticoid receptor 
and sites at which PLP was shown to inhibit (Litwak, et aI, 
1985) . 
Several investigators have found, using rats, a greater 
retention of steriods at target cells during vitamin B-6 
deficiency. This would presumably increase the sensivity of 
the end-target cell to the steriod. Studies on the 
significance of the interaction between PLP and steroids 
24 








OTHER REGU\.ATORY SITE 
FIG.ll PLP and glucocorticoid receptor functional sites 
2.6 METABOLISM OF VITAMIN B-6 
2.6.1 Absorption 
In the rat intestinal absorption of pyridoxine and other 
forms occurs via a non-saturable passive process. However, 
Middleton (in Leklem, 1988) found a saturable component of 
uptake in the rat intestine. If this mechanism exists in 
humans, it would have implications for large supplemental 
25 
intakes. The uptake of phosphorylated forms occurs via 
hydrolysis by alkaline phosphatase. Phosphorylated forms 
can also be absorbed at high levels (Leklem, 1988). 
2.6.2 Metabolism and Transport 
PL, PN, and PM are forms in which most dietary vitamin B-6 
reaches the circulation. They are rapidily transported into 
organs and tissues. (Ink and Henderson, 1984). The liver 
and the erythrocyte are important in defining the 
predominant vitamin forms found in blood plasma. Uptake 
into the liver occurs by facilitated diffusion. The liver 
is the primary organ for the interconversion and metabolism 
of the three forms of vitamin B-6 . The metabolic steps 













































































































































































































































































































The two metabolic steps common to all three forms are 
phosphorylation and dephosphorylation. In the phosphoryl-
ation step a phosphate group is attached at a 5' position 
via pyridoxal kinase and during dephosphorylation this group 
is removed by a phosphatase enzyme, probably alkal ine 
phosphatase. PMP and PNP are then converted to PLP by 
pyridoxine (pyridoxamine)5-phosphate oxidase which requires 
flavin mononucleotide (FMN). Pyridoxal produced by either 
dephosphorylation of pyridoxal-5-phosphate or that which is 
taken up by the liver is converted to 4-pyridoxic acid 
(4-PA) by aldehyde oxidase and/or an NAD dependant 
dehydrogenase. This is the process by which excess intakes 
of vitamin B-6 is metabolized (Leklem, 1988). 
PLP formed in the liver is either utilized in the liver or 
released into the circulation. Al though the liver was 
considered to be responsible for synthesis of the PLP found 
in plasma, it has been suggested that muscle may also 
release PLP into the plasma during caloric deficit (Leklem, 
1988) . 
PLP in the plasma is tightly bound to albumin, a mechanism 
which protects it from hydrolysis and permits delivery to 
other tissues. Plasma also contains other forms of vitamin 
B-6. Under conditions of normal intake plasma PLP is found 
28 
in the highest concentration (60% to 70%) followed by PL, PN 
and PM in decreasing order. PMP and PNP are very low in 
concentration and may not be found (Leklem, 1988). 
Thus PLP and PL (and perhaps PL in the erythrocytes) are 
the forms available to other tissues. However, PLP has to 
be hydrolysed by alkaline phosphatase first before uptake 
into the cells (Leklem, 1988). 
A schematic diagram proposed by Lumeng et aI, 1985 depicted 
in Fig. 13 shows the interconversion and transport of 
vitamin B-6 vitamers in plasma after pyridoxine ingestion. 
The importance of the liver and red blood cell in pyridoxine 
metabolism is clearly depicted by this diagram but essential 
differences occur. While pyridoxine is mainly metabolized 
to PLP, PL, and 4-PA in liver, the erythrocyte converts PN 
to PLo These end metaboli tes then appear in the plasma. 
This conversion of PN to PL and PLP by the liver and 
erythrocytes are very important for vitamin B-6 coenzyme 
synthesis in tissues that lack PMP (PNP) oxidase such as 
skeletal muscle, heart, lung, pancreas etc. (Lumeng, 1985). 
Thus skeletal muscle, which is the maj or repository of 
vitamin B-6 cannot effectively convert PN to PLP or PMP and 
it must rely on a supply of PLP or PL provided by other 
29 
tissues. This example emphasizes the importanc
e of 
interorgan transport of B-6 vitamers in the overall 
scheme 
of mammalian vitamin B-6 metabolism (Lumeng, 1985). 
ABSORPTION BY 
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FIG.13 A proposed pathway for the conversion and tran
sport 
of vitamin B-6 compounds in plasma after PN ingestion
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2.7 ROLE OF THE ERYTHROCYTE IN VITAMIN B-6 METABOLISM 
The pathway for conversion of PN to PLP is the same as in 
the liver. As illustrated in Figure 14, albumin bound PLP 
is incapable of entering the erythrocyte in the presence of 
plasma proteins. PN and PL enter by passive diffusion. PN 
is phosphorylated and 'metabolically trapped' within the 
erythrocyte and is rapidily oxidized by an FMN - dependent 
oxidase to PLP. The human erythrocyte has oxidase activity, 
while the rat lacks it (Reynolds and Natta, 1985). 
PL which diffuses in the erythrocyte is rapidly and 
predominantly bound to the hemoglobin such that very little 
is phosphorylated to PLP. Thus PL undergoes 'metabolic 
trapping' by binding to a protein rather than 
phosphorylation. PL tends to remain in the erythrocyte 
because of its greater binding affinity to hemoglobin than 
albumin (Reynolds and Natta, 1985; Lumeng et aI, 1985). 
Complicating the role of the erythrocyte as a source of PLP 
and PL for other tissues is the binding of PL and PLP to 
hemoglobin. They bind at different sites and have different 
binding affinities. 
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2.7.1 significance of Red-cell metabolism of vitamin B-6 
PLP 
pyridoxal phosphate binds to the red cell at the same site 
as 2,3 diphosphogylcerate (DPG) and ATP bind. It also binds 
less firmly at another site. Pyridoxal phosphate was also 
found to lower the oxygen affinity of hemoglobin 
facilitating oxygen unloading as the above two compounds. 
Due to the large amount present, DPG plays a large part in 
lowering oxygen affinity. However on a molecular basis DPG 
and pyridoxal phosphate were equally effective in this 
function (Anderson, 1980). 
PL 
PL also binds to hemoglobin but to the a-chain and increases 
the oxygen binding affinity, whereas PLP binds to the 
,B-chain of hemoglobin and decreases the oxygen binding 
affinity (Reynolds and Natta, 1985). 
It has been shown after doses of pyridoxine that significant 
uptake by the red cell occurs in vivo and in vitro and 
pyridoxal present in blood is due to red cell conversion. 
The red cells, thus acts as a "factory" and a "reservoir" 
for pyridoxal, maintaining a constant ratio between red 
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cells and plasma whether pyridoxal is formed in the red cell 
or taken up from outside. 
Pyridoxal phosphate is not able to enter red-cells because 
of its strong binding to albumin. This is probably also 
the reason for its inability to enter other cells. This is 
supported by its slow clearance from plasma. Thus pyridoxal 
may be the transport form of vitamin B-6 as it is able to 
enter cells (Anderson, 1980). 
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2.8 ASSESSMENT OF VITAMIN B-6 NUTRITIONAL STATUS 
The four most commonly used tests to assess vitamin B-6 
status in humans include: 
2.8.1 Measurement of vitamin B-6 vitamers in serum or blood 
plasma. PLP is the most commonly used parameter to test for 
for adequacy of vitamin B-6 stores. It is a direct measure 
of the active coenzyme and is reflective of tissue levels 
(Leklem and Reynolds, 1981). Data collected by Lumeng et 
aI, 1978 indicate that plasma PLP concentration is a valid 
indicator of vitamin B-6 nutrition as it increases with 
pyridoxine intake in the range between 0-100~g/day. It also 
correlates well with the PLP content of skeletal muscle, the 
maj or storage pool of vitamin B-6 compounds in the rat. 
However, Masse et aI, 1988 suggested that the use of PLP 
alone to assess vitamin B-6 status maybe misleading. 
Measurement of the total concentration of vitamin B-6 
aldehyde vitamers is suggested. Endogenous PLP is inversely 
related to alkaline phosphatase as demonstrated by other 
investigators. The hydrolytic action of this enzyme may be 
responsible for the elevation in plasma PL concentration. 
Hence PL was chosen to assess the vitamin B-6 status in rats 
in the present study. 
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2.8.2 Measurement of various PLP dependent enzymes in 
erythrocytes with and without added PLP. Pyridoxal 
phosphate is added in vitro to the incubation mixture and 
the percentage stimulation of transaminase acti vi ty in 
erythrocytes is measured. This is compared to the 
transaminase activity in an incubation mixture without PLP 
and is used to measure adequacy of PLP stores in tissues. 
2.8.3 Measurement of excretion of tryptophan metabolites in 
urine following a tryptophan load. This is also a useful 
indicator of vitamin B-6 status. This is a suitable 
technique for use in population surveys. It is however 
unsuitable in nutritional studies where the nutrient balance 
has to be maintained. Although widely used, results have to 
be interpreted with care as other metabolic and hormonal 
factors are known to be involved in tryptophan metabolism 
(Driskell, 1984). 
2.8.4 Measurement of the excretion of pyridoxic acid, the 
inactive degradative metabolite of pyridoxal phosphate. 
Measurements of pyridoxic acid excretion are indicative of 
immediate dietary intakes of the vitamin and probably not 
indicative of body reserves (Driskell, 1984). 
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2.9 ASSAY PROCEDURES FOR VITAMIN B-6 
2.9.1 Animal bioassay using either rats or chicks were used 
in the 1945-1955 era. The sample can be fed directly and 
the problems associated with other methods can be left to 
the enzyme machinery of the animal. However, accurate assay 
requires large numbers of animals and a time period usually 
involving weeks. Hence these methods are very slow and very 
expensive. These methods have been replaced by other 
techniques (Snell, 1981). 
2.9.2 The standard method for the quantitation of vitamin 
B-6 in foods is via microbiological assay. According to 
Polansky, 1981, "the microbiological method using S. uvarum 
which was selected for its specific response to vitamin B-6, 
is still the most widely used method for the estimation of 
total vitamin B-6 in foods." The sample must be hydrolysed 
first as the yeast only grows on the free forms of vitamin 
B-6; generally the sample is suspended in a certain 
normality of HCl and autoclaved. The growth response of the 
organism is measured in a vitamin B-6 free basal medium to 
which either a sample or a standard is added (Driskell, 
1984) . 
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PN, PL and PM are equally active for Saccharomyces uvarum 
although certain strains have been reported to respond to a 
greater extent to PM. The procedures involved in such 
assays are time consuming with added disadvantages such as 
varialibility in the growth response of various 
micro-organism in the vitamin, mutation in micro-organisms, 
and growth inhibitory substances in the sample (Driskell, 
1984) . 
2.9.3 Currently available chemical techniques have been 
reviewed by Dakshinamurti and Chauhan, 1981. Gas-liquid 
chromatography (GLC) has been used for the detection and 
quantitation of vitamin B-6. Prederivatization is essential 
for GLC analysis because of the low volatility of vitamin 
B-6 compounds. Williams, 1974 has reviewed in detail the 
GLC methodology for vitamin B-6 compounds. Some of the dis-
advantages of using this method are the sensivity of many of 
the derivitization methods to water or alcohol and the need 
to remove non volatile materials (Gregory and Kirk, 1981). 
2.9.4 Recent developments concerning HPLC (high performance 
liquid chromatography) have made this technique competitive 
wi th GLC in speed and resolution of complex mixtures 
(Driskell, 1984). HPLC procedures were found to be 
reproducible, and speedy with minimal sample clean up. 
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2.10 VITAMIN B-6 REQUIREMENT OF THE RAT 
Several studies have indicated that the level of protein in 
the diet affects the metabolism of vitamin B-6. Studies on 
rats have shown that when the vitamin B-6 intake is 
inadequate the lower levels of the vitamin is inversely 
proportional to protein intake. However, when vitamin B-6 
intake was adequate, high dietary protein favoured liver 
storage of the vitamin. It was found that when rats were 
fed a higher ration of casein they developed acrodynia 
earlier and had a greater growth retardation. The 
increased vitamin B-6 requirement caused by the high protein 
intake may be due to an induction in the activities of amino 
acid metabolizing enzymes that need PLP (Olson, 1987). 
Clarification of the role of intestinal microflora in the 
metabolism of vitamin B-6 is important in the determination 
of vi tamin B-6 requirements in rats. Intestinal 
micro-organisms can synthesize vitamin B-6 in humans and 
other monogastric animals. The extent of synthesis in the 
rat is markedly influenced by diet composition. The extent 
of absorption and contribution to the metabolism of dietary 
vitamin B-6 by intestinal microflora is unclear. However 
recent data indicate that intestinal micro-organisms do not 
contribute significantly to qualitative and quantitative 
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aspects of vitamin B-6 metabolism in adequately nourished 
rats. The above has not been examined in marginal or 
overtly deficient animals (Rosenburg, 1989). 
Beaton and Cheney, 1964 suggested that the pyridoxine 
hydrochloride requirement for maximal weight gain is at 
least 40ug/day and may approximate 80~g/day. He found that 
for maximal erythrocyte GOT activity the requirement range 
was in the 40 to 80~g/day range while erythrocyte GPT 
activity responded to dosages as high as 80~g/day. On the 
basis of his results he suggested that rats should take in 
about 100g of pyridoxine hydrochloride (PN HCI) per day. 
This would be equilavent to about 60 to 70 mg PN.HCI per 109 
diet. This was confirmed by Mercer, et aI, 1984. 
Driskell et al, 1973 found that curiosity responses, 
pyridoxal phosphate, DNA, RNA and protein compositions of 
the brain reached a plateau at 30~g of PN intake daily. 
General activity responses 
'-". 
and alanine aminotransferase 
activities reached a plateau at 45~g of PN intake daily. 
Based on the above parameters they suggested 45~g daily as 
the vitamin B-6 requirement for weanling and sexually mature 
male rats. Van den Berg et aI, 1982 found that 24~g/day was 
needed for maximal growth of rats. 
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The American Institute of Nutrition (AIN) report on 
standards for nutritional studies (1977) recommended 7mg 
PN.HCl per kg of diet for adequate growth, gestation and 
lactation of rats. 
Thus it can be concluded that the vitamin B-6 requirement of 
rats ranges between 24~g/day and 100~g/day. Anything above 
or below could lead to undesirable metabolic changes. 
2.11 MANIFESTATIONS OF VITAMIN B-6 DEFICIENCY IN THE RAT 
vitamin B-6 deficiency in the rat results in a dermatitis 
resembling that of essential fatty acid deficiency. The 
dermatitis (also known as acrodynia) is observed on the 
tail, paws, nose, chin and upper thorax of vitamin B-6 
deficient rats. In addition the deficiency produces poor 
growth, muscular weakness, fatty liver, convulsive seizures, 
anemia, reproductive impairment, oedema, nerve degeneration 
and impaired immune responses (Rutishauser, 1982). 
Behavioural alterations in general activity curiosity scores 
and avoidance learning have also been reported (Driskell, 
1984) . 
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2.12 DISEASES ASSOCIATED WITH VITAMIN B-6 METABOLISM OR 
UTILIZATION 
2.12.1 Atherosclerosis 
Rinehart and Greenburg, 1949 were the first to associate 
vitamin B-6 deficiency with vascular disease. They found 
that sclerotic lesions had developed in arteries of monkeys 
fed a pyridoxine deficient diet. Few studies have been 
carried out to assess the implications of these findings in 
humans. However, Serfontein et aI, 1985 showed in a pilot 
study that plasma PLP in myocardial infarction (MI) patients 
was lower than healthy controls. It was also suggested 
that plasma PLP levels may be a far more sensitive indicator 
of myocardial infarction (MI) than plasma cholesterol or HDL 
values. Kok et aI, 1989 found that all levels of vitamin B-6 
indices except PL were lower in MI patients compared to the 
controls. It is suggested that the low levels may be 
implicated in the pathogenesis of the disease or may be as a 
consequence of MI. 
Although the latter has not been ruled out, there are also 
several mechanisms whereby PLP could contribute to the 
progression of the disease. The mechanisms are as follows: 
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2.12.1.1 Sulphur amino acid metabolism 
Atherosclerotic changes and thrombo-embolism commonly occur 
in homocysteinuric patients and infusion of homocysteine 
causes atherosclerotic lesions (Labadarios and Shephard, 
1985). Several groups have proposed that elevated plasma 
levels of homocysteine due to marginal vitamin B-6 
deficiencies could be a maj or contributory factor in 
atherosclerosis (Merrill and Henderson, 1987). The 
homocysteine theory of atherosclerosis is the most developed 
hypothesis of the three general mechanisms reviewed (Willet, 
1985) . 
2.12.1.2 Lysyl Oxidase 
Lysyl oxidase is an extracellular enzyme which is involved 
in elastin and collagen cross linking. It is Cu and PLP 
dependent. 
Starcher, 1969 confirmed an earlier hypothesis that 
pyridoxine deficiency, like Cu deficiency, in chicks does 
reduce the rate of lysine oxidation in aortic elastin and 
the amount of desmosine and isodesmosine formed. He 
supported earlier suggestions that a pyridoxine cofactor is 
required for enzymatic lysine oxidation. 
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Elastin and collagen are the major fibrous proteins of the 
arterial wall. They are cross linked so that arterial 
structure may be restored after systole and diastole. Their 
cross linking is initiated by lysyl oxidase, which 
oxidatively deaminates lysine or hydroxylysine residues to 
their aldehydic derivatives. Levene and Murray, 1977 found 
strong evidence that lysyl oxidase, in addition to being Cu 
dependent, also required PLP. This claim has been refuted 
by Willett, 1985. 
Levene and Murray, 1977 hypothesized that the earliest 
visible lesion of atherosclerosis found in human neonatal 
coronary arteries was a 'focal splitting' of the internal 
elastic lamina. They hypothesized that "this lesion is the 
result of imperfect cross linking of arterial elastin and 
collagen and is caused by a maternal deficiency of vitamin 
B-6 which is commonly found in pregnancy and which could 
thus impair the function of lysyl oxidase." 
2.12.1.3 It has been suggested that low vitamin B-6 intake 
in rats and rabbits may increase the risk of coronary heart 
disease by raising serum cholestrol (Willet, 1985). 
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2.12.2 Hematological Disorders 
The prototypical pyridoxine responsive anemia is 
characterized as having severe hypochromic, microcytic 
cells, elevated serum Fe and low erythrocyte protoporphyria. 
Most cases appear to have abnormalities in Fe metabolism 
suggestive of a genetically determined error in metabolism 
which results in increased dependance of erythropoiesis on 
vitamin B-6 (Labadarios and Shephard, 1985). 
There is extensive literature regarding "pyridoxine 
responsive" anemias. Patients with sideroblastic anemia 
have shown an "optimal response" to pyridoxine therapy. 
While some patients responded others did not. The variable 
responsiveness to pyridoxine has not been explained 
reasonably (Merrill and Henderson, 1987). 
One of the explanations for the response to pyridoxine 
therapy concerns a defective o-aminolevulinate synthase 
(ALA-S) that results on a low affinity for PLP. Thus 
pyridoxine supplements are effective in patients with 
decreased ALA-S activity (Merrill and Henderson, 1987). 
Bishop and Bethel, 1959 reported an observation on a man 
with hereditary hypochromic anemia and hemosiderosis who 
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demonstrated a therapeutic response to pyridoxine. He was 
not vitamin B-6 deficient. They suggested that the excess 
Fe stores and the increased iron concentration at the site 
of hemoglobin synthesis caused the formation of an Fe-PL 
complex that prevented the normal function of pyridoxal as a 
coenzyme in heme synthesis. The high doses of pyridoxine 
given may have prevented this inhibition and allowed heme 
synthesis to continue (Bishop and Bethel, 1959). 
Sideroblastic anemia is a rare disorder in which varying 
numbers of hypochromic microcytic red cells are found in the 
blood and normoblasts containing an excess of Fe containing 
granules appear in the marrow. There are also increased Fe 
stores in the reticulo-endothelial system and in 
parenchymatous organs such as the liver, pancreas and heart, 
the serum cholestrol is raised and Fe binding protein is 
raised (Houston, 1985). 
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2.13 VITAMIN B-6 AND ITS INTERRELATIONSHIP WITH TRACE 
ELEMENTS 
One of the most important functions of essential trace 
elements is their necessity for a large number of enzymes. 
Their association with enzymes is of two types, they may be 
an integral part of the enzyme protein molecule (metallo-
enzymes) or they may be "activators" of the enzyme (metal 
ion activated enzymes) . 
vitamin B-6 is also involved in many vital enzymatic and 
regulatory processes which have already have been discussed. 
Considering their wide involvement in metabolism, their 
involvement as catalysts in common pathways is inevitable. 
Consequently, it is not unexpected that diverse interactions 
exist between vitamin B-6 and trace elements. 
2.13.1 Pyridoxine deficiency and Fe metabolism 
Neal and Pearson, 1962 investigated the relationship between 
pyridoxine deficiency and Fe uptake at various levels of Fe 
intake. They found that pyridoxine deficient rats did not 
absorb increased amounts of Fe when their Fe intake was 
100~g/day. They estimated the Fe requirement of rats to lie 
in the range of 50 to 100~g/day. When the Fe was increased 
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to 1mg/day pyridoxine deficient rats showed a significantly 
greater Fe absorption than the controls. They concluded 
that enhanced iron absorption in the pyridoxine deficient 
rat does not occur under physiological conditions. 
Another study was carried out by Kirksey A. et aI, 1967 to 
investigate: 
the effect of pyridoxine deficiency on normal increase 
in Fe absorption during late pregnancy. 
the effect Fe supplementation on reproductive 
performance and tissue stores. The diet given 
contained 200mg of Fe per day. The results relevant to 
the present studies were as follows: 
Pyridoxine deficiency resulted in: 
impaired erythropoiesis including polycythemia, reduced 
mean corpuscular hemoglobin (MCH) and mean corpuscular 
volume (MCV). 
Liver Fe stores were elevated in the non-pregnant 
deficient rats. 
Spleen Fe stores were elevated. 
No major impairment in Fe absorption was apparent. 
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A high level of Fe found in duodenum of pyridoxine 
deficient group was possibly part of a regulatory 
mechanism which blocked excessive absorption of iron as 
this group had elevated iron stores and therefore the 
need for Fe was less. 
Kirksey et aI, 1967 suggested that the elevation of Fe in 
tissues in the deficiency may be due to a decreased 
utilization of Fe in hematopoiesis. During a pyridoxine 
deficiency one would expect decreased availability of PLP 
which is required for the biosynthesis of hemoglobin. 
Although the hemoglobin concentration was not altered during 
the deficiency, polycythemia accompanied by significantly 
lower MCH and MCV were evidences of the effect of the 
deficiency on hematopoiesis (Kirksey and Tabacchi, 1967). 
Kirksey et aI, 1969 observed elevated plasma Fe and 
tranferrin in pyridoxine deficient mothers. Although they 
attributed this to less expansion of blood volume during the 
deficiency the possiblity of increased Fe absorption was not 
ruled out. The marked incease in tranferrin saturation in 
maternal circulation found are consistent with increased Fe 
absorption. 
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A confirmation of their former findings were reflected in 
elevated Fe content of the liver, spleen, and duodenum of 
pyridoxine deficient mothers (Kirksey, et aI, 1969). 
Ikeda et aI, 1979 also found vitamin B-6 deficient 
conventional and germ free rats retained more Fe in their 
tissues than the control animals. The liver and kidney Fe 
were significantly increased in the conventional deficient 
group. 
2.13.2 vitamin B-6 and Zn metabolism 
HSu, 1965 found that a pyridoxine deficiency resulted in a 
decrease in Zn content in the plasma, liver, pancreas and 
heart tissue. No alterations were noted in the kidney and 
spleen. 
He also observed an increase in Zn-65 uptake in the plasma 
and liver after an intramuscular injection of radiozinc. 
The gastrointestinal tract and faeces also displayed a 
highly significant increase in zinc radioactivity. This 
would suggest that a pyridoxine deficiency enhances the rate 
of excretion of radiozinc from the body. 
49 
other investigators noted that certain zinc containing 
enzymes such as liver lactic acid dehydrogenase and plasma 
alkaline phosphatase displayed altered activities in 
pyridoxine deficient rats. Huber et al (in Hsu, 1965) 
indicated that less insulin activity existed in pyridoxine 
deficient rats. However it is not clear whether this was 
due to Zn deficiency or pyridoxine deficiency. 
Gershoff's (1967) observations were contrary to Hsu' s 
findings. He found that vitamin B-6 deficiency resulted in 
increased pancreatic, serum and kidney zinc levels in rats. 
When he fasted his control and deficient groups for 24 hours 
he found that fasting resulted in a considerable increase in 
Zn in the liver, serum, pancreas and kidney. Except for 
serum the effect of fasting on Zn levels was not significant 
in vitamin B-6 deficient rats. In addition to fasting he 
found that pair-feeding of the control group resulted in a 
significant rise in Zn content of the pancreas and kidney. 
Because of this there were no significant differences in the 
Zn levels between the deficient and pair-fed control groups, 
Gershoff, 1967 used his data to explain Hsu's conclusions. 
Hsu pair-fed and fasted his rats overnight before 
determining tissue Zn levels. Thus, according to Gershoff, 
Hsu's conclusion that vitamin B-6 deficiency in rats reduced 
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tissue Zn content was in greater part a reflection of the 
high tissue levels of Zn in his fasted controls. 
The results of Gershoff was supported by Ikeda et aI, 1979 
who also found elevated Zn levels in the kidney of 
conventional rats and in the liver and spleen of germ free 
rats. No significant change was found in the liver, 
pancreas, spleen, lung and testis of the deficient 
conventional group compared to the control. 
In a study undertaken by Prasad et aI, 1982 it was found 
that a significant enhancement in the uptake of Ca, Zn, and 
Cd occurred in the intestine of vitamin B-6 deficient rats 
as compared to the control or pair-fed animals. A lack of 
specificity on the uptake of all three metals is highlighted 
by the fact that all three have a distinct mode of transport 
from the brush border. These observations support the 
increased Zn content of tissues in vitamin B-6 deficiency 
found by Gershoff and Ikeda. 
Prasad et aI, 1982, suggested that the lack of pyridoxine 
may result in impairment of nucleic acid synthesis leading 
to inhibition of protein synthesis, cell division and 
repair. The involvement of the coenzyme form in the 




with nitrogen metabolism is well 
it would be probable that a marked 
alteration could be expected in the brush border membrane 
which may lead to a non-specific increase in metal-ion 
uptake. 
2.13.2.1 The Effect of vitamin B-6 and Tryptophan on Zn 
absorption 
Evans, 1980 stated after nearly a decade of research that 
mammals have evolved an efficient method of transporting Zn 
through a barrier created by the absorptive cells of the 
intestine by a process that involves synergism among Zn, 
vitamin B-6 and tryptophan. 
In 1973, Hahn and Evans (in Evans, 1980) detected a low-
molecular weight «1,500 daltons) zinc binding ligand (ZnBL) 
later identified as picolinic acid in the lumen wash and 
intestinal mucosal cells of rats. They also found that 
human milk and a pancreatic extract, both of which contain a 
substantial quantity of picolinic acid, have been effective 
in treating the symptoms of acrodermatitis enteropathica 
(resulting from impaired Zn absorption) . 
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Evans, 1980 found that addition of picolinic acid to rat 
diets promoted growth and increased absorption and retention 
of dietary Zn. The production of picolinic acid from 
tryptophan is dependent on pyridoxal. Picolinic acid added 
to a vitamin B-6 deficient diet resulted in an increase in 
kidney Zn concentration compared to an unsupplemented diet. 
Therefore if endogenous picolinic acid facilitates dietary 
Zn absorption, a deficiency of either vitamin B-6 or 
tryptophan should impair Zn absorption. However, Hsu found 
no change in kidney Zn content between deficient and control 
animals. 
This should explain Hsu's, findings of a decreased Zn level 
in certain tissues during pyridoxine deficiency. Evans, 
1980 found that rats fed 2, 4, 10 and 40mg PN. Hel per 
kilogram diet absorbed 150, 165, 195 and 233g Zn per day 
respectively. They also found that rats fed a diet low in 
tryptophan absorbed less zinc. Hence, because picolinic 
acid is a tryptophan metabolite and depends on pyridoxine 
for its production, these results provide strong evidence 
that endogenous picolinic acid is essential for normal Zn 
absorption. 
In a another study undertaken by Evans and Johnson, 1980 
they found that Zn absorption in rats fed a high iron diet 
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(300ppmFe, 16,5ppm Zn) was significantly less than in rats 
fed an adequate Fe (220ppm Fe, 16,5ppm Zn). When the high 
Fe diet was supplemented with picolinic acid, Zn absorption 
was increased and did not differ from that in rats fed the 
adequate Fe diet. 
Zn absorption and pancreatic picolinic acid concentration 
increased as dietary level of vitamin B-6 was increased in 
the high Fe diet. Therefore, the inhibitory effect of high 
Fe on Zn absorption was decreased by the exogenous and 
endogenous production of picolinic acid. 
They also found increased Zn retention in rats fed higher 
levels of vitamin B-6. This was attributed to increased 
endogenous picolinic acid production which increased the 
efficiency of Zn absorption. 
Evans and Johnson, 1980 concluded that picolinic acid is the 
ligand, found in the pancreas, that facilitates Zn 
absorption. It is secreted from the pancreas into the 
intestine during digestion and may form a Zn-dipicolinate 
complex. This complex due to its specificity for receptor 
sites on the absorptive cell or because of its high 
association constant facilitates the transport of Zn and 
other divalent cations into and across the intestinal cell. 
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Another important conclusion was that high levels of dietary 
Fe inhibit Zn absorption via competition for binding with 
endogenous picolinic acid. 
These results provide further evidence to support the 
hypothesis that picolinic acid facilitates the absorption of 
dietary Zn. 
However Hurley and Lonnerdal, 1980 identified citrate as a 
zinc binding ligand in human milk and stated that the 
apparent effectiveness of Viokase (a commercial pancreatic 
extract) in increasing Zn absorption in patients suffering 
from acrodermatitis enteropathica maybe due to its citrate 
content. They also failed to identify picolinic acid in the 
pancreas. Furthermore it was found that picolinic acid is 
not a significant end product of tryptophan in the rat. 
Only 7,4% OF 3-0H anthranilic acid was converted to 
picolinate by rat liver extracts and only 4% was converted 
to urinary picolinate in vivo. 
They did not agree with Evans' conclusions that impaired Zn 
absorption in protein deficiency is due to decreased levels 
of picolinic acid resulting from lack of adequate 
tryptophan. They hypothesize that the decrease in Zn 
absorption may be as a result of breakdown of intestinal 
mucosa caused by protein deficiency. 
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They agreed that picolinic acid is a good chelator of zinc. 
But state that increasing zinc absorption by adding a 
chelating agent in no way indicates that the chelating 
compound has a normal physiological role (Hurley and 
Lonnerdal, 1980). 
2.13.3 VITAMIN B-6 AND COPPER METABOLISM 
Al though no studies have been found in the literature 
concerning the effect of vitamin B-6 on copper metabolism 
the likelihood of an interrelationship is very strong. The 
fact that certain Cu metalloenzymes need PLP as a cofactor 
supports this statement. 
Amine oxidases of the plasma, kidney and liver are copper 
proteins. The amine oxidases of the plasma and kidney also 
contain firmly bound pyridoxal phosphate (Gray and Daniel, 
1973) . 
Lysyl oxidase of the chick aorta was shown to be sensitive 
to a vitamin B-6 or copper deficiency (Starcher, 1969). 
Lysyl oxidase is responsible for the normal crosslinking of 
both collagen and elastin which is necessary for their 
functional integrity. Whether this enzyme is vitamin B-6 
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deplendent needs confirmation (Levene and Murray, 1977). 
This aspect has been reviewed under atherosclerosis. 
Dopamine ~-hydroxylase plays an important role in central 
nervous system functions as it is involved in noradrenaline 
synthesis. It is a copper metalloenzyme and is dependent on 
PLP. 
The close interdependence of eu and Fe also warrants an 
investigation of both trace elements in pyridoxine 
deficiency. 
It has been shown that copper is needed to ensure the proper 
amount of hemoglobin in blood. 
In the swine eu deficiency leads to: 
defective absorption of Fe from the intestine. 
a restricted flow of Fe from the reticuloendothelial 
cells to the plasma. 
excessive retention of Fe in the liver and 
impaired production of haemoglobin (Prasad, 1978). 
It has been shown that eu deficiency results in a reduction 
of tissue content and a decrease in plasma eu which leads to 
anemia - a hypochromic, microcytic anemia. 
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It appears that the Cu deficiency in animals results in 
impaired ability of the duodenal mucosa, the 
reticulo-endothelial system and the liver to release Fe to 
the plasma. This is suported by the hypothesis that 
ceruloplasmin (ferroxidase) is the enzyme thats needed for 
transfer of Fe from tissues to plasma (Peereboom, 1985; 
Prasad, 1978). 
2.14 ASSESMENT OF TRACE ELEMENT STATUS 
This section will briefly outline the methods used to assess 
trace element status. Although these tests are referred to 
as assessments of trace element status few, if any, provide 
measurements of or indications of total body content of 
trace elements. They simply "assess whether the activity 
(available concentration) of a given trace element is 
sufficient to maintain the rates and extent of the element 
dependent metabolic reactions within normal limits, or 
whether there is an excess or deficiency of this activity 
that could produce a biochemical defect and lead to a 
clinical abnormality" (Delves, 1985). 
Some of the methods used to assess trace elements status 
given in order of importance are: 
Measurements of trace element concentrations in body 
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tissues, fluids, cellular and extracellular fractions 
and in serum proteins. 
Assay of element - specific activity in body tissues 
and fluids. 
In vitro uptake of radioisotopes by tissue. 
Trace element balance studies. 
Biochemical and clinical responses to administration of 
trace element. (Delves, 1985) 
According to Delves, 1985 none of these methods are ideal 
and the method used will depend upon the element being 
investigated. 
In the present study tissue content of Fe, eu and Zn were 
analysed. 
2.14.1. Zinc in body tissues 
Jackson et aI, 1982 have found that dietary depletion of 
zinc was found to result in a 30% decrease in total body 
zinc content in rats. In depleted animals he found no 
decrease in zinc content of hair, skin, heart or three 
different skeletal muscle. However levels of plasma, liver, 
bone and testes were significantly reduced when rats were 
put through a dietary treatment for 80 days. Several other 
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workers have shown that experimental zinc deficiency causes 
a decrease in zinc content of various animal tissues 
(Jackson et al, 1982). 
Against this background and owing to the relatively high 
levels of zinc in rat muscle, heart and kidney. (Prasad, 
1978) these tissues were chosen for analysis. However, 
after the completion of this study a relatively recent 
article by Golden, 1989 shows that the measurement of tissue 
content is not a valid assessment of Zn status. 
He proposed that two types of nutritional deficiencies 
existed. During a Type 1 nutrient deficiency a reduction of 
tissue concentration is observed. However, during a Type 11 
nutrient deficiency there is almost no reduction of the 
tissue element content. Zn deficiency falls into the latter 
category. 
Golden, 1989 states that in both mild and severe 
experimental Zn deficiency, there is almost no reduction in 
the tissue Zn content. Muscle zinc is preserved. A small 
decrease in liver and pancreatic Zn is found in prolonged, 
profound deficiency. 
zinc is bone. 
The only tissue with a reduction in 
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2.14.1.1 Type 11 Nutrient Deficiency 
Zn deficiency falls into this category. If the animal is at 
stage of development where sensitivity to Zn is high, it 
stops growing, without a reduction in tissue concentration 
when given a diet low in Zn. The clinical signs that 
develop is usually due to external factors such as stress or 
trauma. This makes this type of deficiency very difficult 
to diagnose. 
The nutrient ego Zn is locked in tissues and is fundamental 
to the composition, integrity and day-to day functioning of 
that tissue. Although Zn would be released if the whole 
tissue is catabolized, small amounts are released if there 
is metabolic re-adjustment. This re-adjustment may be 
totally unrelated to the defic i ency of Zn ego if there is a 
reduction in protein this will result in a alteration in Zn 
metalloenzyme activity leading to a slight decrease in 
functional tissue zinc concentration. 
re-adjustments are proportionately small. 
These metabolic 
The reduction in 
protein synthesis rate is probably the reason for the small 
changes in liver and pancreatic Zn concentrations observed 
in Zn deficiency. This change is non-specific (Golden, 
1989) . 
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Type 11 nutrient deficiencies will probably reveal negative 
Zn balances. This is because whole tissue is being broken 
down and the excess nutrient is liberated ego Zn will have 
to be metabolized and excreted. A negative Zn balance is 
probably due to a dietary protein deficiency or to a 
metabolic re-adjustment of the tissue due to the Zn 
deficiency. 
Zn deficiency (Type 11 nutrient deficiency) is characterized 
by a large fixed pool in the tissues and a small rapidly 
turning over, free pool which is sensitive to a deficiency. 
Therefore plasma or serum Zn has most often being used for 
diagnosis of a deficiency. However, Solomons in Golden, 1989 
states that its invalid as a measure as it does not reflect 
total body Zn. Golden argues that total body Zn bears 
little relationship to Zn status in a deficiency as it is 
not a Type I nutrient deficiency. Plasma is an unreliable 
indicator of Zn deficiency becuase it is subj ect to 
metabolic alteration. Research by Golden, 1989 has revealed 
that assay of plasma Zn and red blood cell metallothionein 
-1 can be used to diagnose a Zn deficiency. 
2.14.2 Copper and Iron in body tissue 
According to Golden, 1989 Cu and Fe deficiencies are Type I 
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nutrient deficiencies. This type of deficiency is 
characterized by a reduction in the tissue concentration of 
the nutrient and a defect in one or more specific pathways. 
This results in a loss of function so the deficiency has 
specific clinical signs. 
Hence, unl ike zinc, a dietary intake of eu ad Fe is 
reflected in the tissue levels. Thus measurement of tissue 
content is a valid assessment of eu and Fe status. The 
chain of events that follow this type of deficiency is as 
follows: 
A diet with a low content of Fe or eu will lead to a reduced 
tissue concentration and hence lead to an identifiable major 
defect in the metabolic pathway. This then leads to 
characteristic clinical signs and symptoms. All one has to 
do thereafter is diagnosis (Golden, 1989). 
Hence it can be concluded that trace element analysis of 
body fluids and tissues is very a useful method of 
assessment of eu and Fe status. The liver, being a major 
organ for the metabolism of eu and Fe, is very useful in 
assessing the status of these trace elements (Bacon, 1984; 
Winge 1984). The heart, kidney and muscle were chosen 
because of the relatively high concentrations of eu and Fe. 
63 
For the diagnosis of zinc deficiency, plasma Zn and red 
blood cell metallothionein-1 assay are recommended by 
Golden, 1989. 
A balance study conducted by Channa, 1988 gave an insight 
into the quantity of Cu, Fe and Zn that entered and left the 
body during a given time in a vitamin B-6 deficient state. 
This type of study had no value for defining considerations 
such as internal body distributions, pool sizes, turnover 
rates, molecular uses or metabolic roles of the trace 
elements studied. Also one cannot calculate the true 
intestinal absorption as the magnitude of any endogenous 
contribution to fecal matter cannot be studied using the 
balance studies (Beisel, 1979) . 
Hence assessment of trace element status using measurement 
of tissue content was performed, to shed more light on the 
internal body distribution of trace elements during a 
vitamin B-6 deficiency. 
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CHAPTER THREE 
MATERIALS AND METHODS 
3.1 structure of the study 
Formulation of diets for experimental and control 
animal groups. 
Induction of various levels of vitamin B-6 deficiency 
in the experimental animals. 
Pair-feeding of 1 group of rats with the deficient 
group in the second experiment. 
Recording of food intake daily and body weight weekly. 
Biochemical confirmation of vitamin B-6 status (in all 
groups) by determining plasma pyridoxal levels. 
Digestion of heart, liver, kidney and muscle using a 
wet ashing technique. 
Determination of Cu, Fe and Zn levels in various 
tissues using atomic absorption spectrophotometry. 
statistical analysis of data obtained. 
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3.2 MODEL SYSTEM 
Two sets of experiments were carried out. In experiment 1 
thirty-three young male wistar rats with masses ranging from 
96 - 102 grams were used. 
In experiment 2 thirty-six young male, wistar rats weighing 
approximately 80 grams were supplied by the Biomedical 
Resource Centre (BRC), University of Durban-Westville. 
These rats were housed individually in perspex metabolic 
cages (Techniplast) in an air-conditioned room, in the BRC 
away from laboratory equipment and personnel. The average 
temperature and humidity were 22°C and 55% respectively. 
Automatically controlled illumination with 12 hour light and 
dark cycle was maintained. 
The cages were washed thoroughly using a disinfectant and 
rinsed with deionized water by the BRC. The cages had 
stainless steel grid bottoms that allowed faeces to collect 
in a container under the funnel thus eliminating the 
potential for corprophagy. Food and deionized water were 
available to the animals ad libitum in containers attached 
to the metabolic cages. 
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Rats were assigned three dietary treatments as follows: 
Group 1 (control group) was fed the adequate diet containing 
3,5mg/kg of vitamin B-6 in the form of PN.HCl. 
Group 2 was fed the marginally deficient diet containing 
1,75mg/kg of vitamin B-6 in the diet. 
Group 3 was fed the totally deficient diet containing Omg/kg 














Animal weights were used in assigning rats to the various 
dietary treatment groups to maintain similar group mean 
weights. A pair-fed control group for the deficient group 
was added in experiment 2 because it was anticipated that 
food consumption would be altered by the deficiency of PN. 
The rats were assigned three dietary treatments as follows : 
the diets of groups 1, 2 and 3 contained 3,5; 3,5 and Omg 
per kg of vitamin B-6 in the diet respectively. 
On arrival all rats were fed the control diet for one day. 
A period of one week was allowed to establish the routine of 
pair-feeding before the start of the experimental period. 
Pair-fed rats were given an amount of vitamin B-6 adequate 
food equal to that consumed on the previous week by the rats 
to which it was paired. 
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3.4 DIET PREPARATION 
The pyridoxine diet (ICN Nutritional Biochemicals, 
Cleveland, Ohio) used was based on the formulation by French 
S, 1966. 
The diet used had the following composition: 
vitamin free casein 
Sucrose 
Corn starch 
Alphacel, non-nutritive bulk 
Vegetable oil (hydrogenated) 
Corn oil 
Salt mixture Hawk Os er 
Plus ICN vitamin diet fortification mixture 
except pyridoxine hydrochloride 
Hawk Oser Salt Mixture 
Calcium carbonate 
Calcium citrate 
Calcium phosphate monobasic 
Ferric citrate (16-17% Fe) 
Magnesium carbonate 















Manganous sulphate. H2O 
Potassium aluminium sulphate 
Potassium chloride 
Potassium iodide 
Potassium phosphate dibasic 
Sodium chloride 
Sodium fluoride 
ICN vitamin Diet Fortification Mixture 
Composition 
Vitamin A acetate (500 000 IU/g) 








































The control (3, 5mg/kg of vitamin B-6) and marginally 
deficient diet (1,75mg/kg of vitamin B-6) was prepared as 
follows (Channa, 1988): 
3,5mg PN.HCl (BDH Chemicals, England) was added to 1kg of 
the basal diet to form the stock diet containing 35mg of 
PN.HCl per kg of diet. An electrical homogenizer (Forster 
Equipment Co., England) was used to mix the above for about 
15 minutes. 
Thereafter 250g of the stock diet was added to 2250g of the 
basal diet mixed as described above to yield 3,5mg/kg PN in 
the diet. 
To prepare the marginally deficient diet, 125g of the stock 
diet was mixed with 2375g of basal diet to yield 1,75mg/kg 
PN in the diet. 
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3.5 ISOLATION OF TISSUES 
At the end of eight weeks rats were held overnight in the 
metabol ic cages without food but with free access to 
deionized water. On the following day rats were 
anesthetized with ether. While blood was being removed the 
anesthesia was maintained. Blood samples were obtained from 
the abdominal aorta into heparinized syringes. Samples were 
placed in labelled vials. Blood was centrifugated at 150x g 
for 15 minutes to separate the plasma for PL analysis. 
Plasma samples were frozen at -7°C. 
Subsequent to the removal of blood; kidney, liver, heart and 
muscle were excised using stainless steel instruments, 
blotted and cleansed of adhering matter. Tissues were then 
placed immediately into labelled plastic vials individually. 
All vials were placed in crushed ice and then frozen at 
-7°C. All instruments (stainless steel) used were washed 
thoroughly in double deionized water to prevent 
contamination. All surgical procedures were carried out in 
a laboratory at the Biomedical Resource Centre, University 
of Durban - Westville. 
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3.6 REAGENTS AND GLASSWARE 
The sources and purity of reagents used were as follows: 
Double deionized water (Elgastat water deionizer) from 
Elga limited. 
Nitric acid (Suprapure) from Merck, Darmstadt, F.R.G. 
Zinc (Spectrosol) from B. D. H. Chemicals, Poole, 
England. 
Copper (Spectrosol) from B.D.H . Chemicals, Poole, 
England. 
Iron (Spectrosol) from B. D. H. Chemicals, Poole, 
England. 
All glassware and plasticware used during the experiment 
were cleaned by soaking in an aqueous solution of 20% nitric 
acid for 48 hours. Thereafter all glassware and plasticware 
were thoroughly rinsed several times using deionized water. 
After a brief period of drying they were stored in sealed 
particulate free plastic bags before being used. 
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3.7 PLASMA PL ANALYSIS BY HIGH PERFORMANCE LIQUID 
CHROMATOGRAPHY 
3.7.1 Principle of HPLC analysis 
Chromatography involves the separation of mixtures into 
their various components due to the difference in 
equilibrium distribution of these components between two 
different phases. 






Thin layer (TLC) 
Open column 
Gas (G. C.) 
High performance liquid 
(H.P.L.C.) 
All except G.C. are forms of liquid chromatography i.e. 
sample molecules are transported through the stationary 
phase by a liquid mobile phase. 
Individual molecules are retained by the stationary phase as 
a resul t of interactions between sample molecules I 
stationary phase and mobile phase. The length of time for 
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which they are retained is dependent on the unique chemical 
interactions of each component. Since these differ, the 
retention times differ and separation is achieved. 
The basic method applies to all forms of liquid 
chromatography, viz., we have stationary phase, mobile 
phase, and as a result of the various affinities of the 
sample for each, a separation occurs (Williams amd Wilson, 
1984) . 
In contrast to other chromatographic techniques, HPLC 
employs the principles of adsorption, partition, 
ion-exchange, exclusion and affinity chromatography. Being 
such a versatile technique it has emerged as the single most 
powerful chromatographic technique. The advantages of this 
technique lies in its high efficiency, speed of resolution 
and its use with minute amounts of material (Williams, and 
Wilson, 1984). 
Basically, separation of the sample components is achieved 
by interaction between the sample components and the 
stationary and mobile phase on the column. Detection occurs 
as the sample components emerge from the column, by means of 
a detector system. Results are presented as a series of 
peaks on a chart recording. Retention time is used to 
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identify unknown compenents in the sample. It is defined as 
time from injection of a given compound to its detection. 
The time is the same for a given compound under standard 
conditions. Identification of an unknown sample can be 
achieved by comparing components analysed under identical 
conditions, or by the use of an internal standard (Williams 
and Wilson, 1984). 
3.7.2 Quantification of Plasma PL levels by HPLC 
Ubbink et al devised a novel HPLC method for the 
simultaneous quantificantion of plasma PLP and PL levels. 
It comprises pre-column semicarbazone (SC) derivitization, 
HPLC to separate PLPSC and PLSC from each other and from 
unidenti f ied background components, post column pH 
adjustment and fluorescence detection (Ubbink et al, 1985). 
The semicarbazone derivatization was done in the presence of 
trichloroacetic acid used for deproteinizing (Ubbink et al, 
1986) . This is a modification of a previous method 
described by Ubbink et al, 1985. 
The HPLC separation is a simple, isocratic technique. An 
on-line flow pH meter was installed behind the detector cell 
to monitor pH fluctuations during analysis. 
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Reagents used 
PL and PLP from Merck (Darmstadt, F.R.G) 
Chromatography grade acetonitrile from Merck 
All other chemicals were of analytical - reagent grade 
and were obtained from Merck 
Purification of PL 
The commercial PL preparations were purified by 
reversed-phase HPLC (Whatman Partisil 10 ODS-3 column; 
mobile phase: 10% methanol and 0,1% glacial acetic acid in 
water) and then lyophilized. Purified PL was checked for 
impurities by reversed-phase ion-pair chromotography, UV 
detection (290nm) and wavelength scanning (210-360nm) at 
different stages of peak elution. UV absorption spectra of 
the purified PL was determined in 0.1 M hydrochloric acid, 
0.1 M sodium hydroxide and 0,1 M sodium phosphate buffer, pH 
7.0. 
standard preparation 
Purified PL was used to prepare working standards containing 
1-20ng PLo Equal volumes of standard solution and (SOml 
TCA, 30ml semicarbizide) precipitation reagent was added to 
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labelled vials. The mixture was incubated at 45° for 40 
minutes. 
Sample Preparation 
An equal volume of precipitation reagent was added to 0,5ml 
plasma. The mixture was shaken thoroughly for even protein 
precipitation. The mixture was incubated for 40 minutes at 
45°C. Prior to injection, the samples were centrifuged at 
4000rpms for 15 minutes. 
supernatant to a microvial. 
Instrumentation 
Transferred 200J,Ll of the 
A Beckman (Beckman Instruments, Berkeley, CA, U.S.A.) Model 
112 solvent delivery module was slightly modified so that 
the pump was used for sol vent del i very. An LS 4 
Perkin-Elmer flourescence spectrophotometer (excitation 
367nm, emission : 478nm) was coupled to a Spectra Physics 
(San Jose, CA, USA) 4270 integrator. 
Columns 
A Whatman (Clifton, NJ, USA) Partisphere C'8 analytical 
column (110 x 4.7mm 1.0.; particle size 5J,Lm) was used. To 
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protect the analytical column, a Whatman reversed-phase 
cartridge was installed between the inj ector and the 
analytical column. The guard cartridge was replaced every 
two weeks. 
Chromotographic Conditions 
A solution of 0,05 M potassium dihydrogen phosphate (pH 
adjusted to 2,9 with concentrated orthophosphoric acid) 
containing 4% acetonitrile was used as a mobile phase. 
(2% wjv) was introduced for post column alkalinization. 
NaOH 
The 
flow rates of the solvent delivery pump and the post column 
reagent pump were 1 and O,lml per minute respectively. 
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3.8 ACID DIGESTION OF SAMPLES 
In order to use atomic absorption spectroscopy samples must 
usually be in liquid form, often requiring digestion. 
Hence, the wet ashing technique described by clegg et aI, 
1981, was modified and employed for sample digestion. They 
found that nitric acid proved to be the most effective wet 
ashing agent. with nitric acid, mean concentrations for 
iron, copper and zinc differed from NBS certified values by 
less than 1,5%. 
Frozen samples were first thawed and weighed thereafter. 
Tissue weights used were approximately 0,5g. Liver, kidney, 
muscle and heart samples from all 69 rats were wet digested 
in 50ml Kjeldahl flasks containing 3 glass beads in nitric 
acid. The volume of nitric acid used was 6mls. All samples 
were predigested at room temperature for approximately 12 
hours before heating began. Samples were subsequently 
heated to maintain constant boiling until evolution of 
nitric acid fumes (Clegg et aI, 1981). 
Batches of 4 samples including a blank and blank containing 
a standard were digested for 4 hours at a session. At the 
end of the digestion period, samples had a very slight clear 
yellow tint. After completion of digestion , the contents 
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of the flasks were cooled and thereafter transferred to 25ml 
volumeric flasks. The inside of the flask was rinsed 
several times with deionized water to ensure complete 
transfer of acid digest. Digested samples were brought to 
volume with deionized water. A blank and blank containing a 
known quantity of STD were included with a batch of 4 
samples. 
Recovery Studies 
12 male, adult wistar rats were used to standardize the 
ashing and atomic absorption methods. Liver, heart, kidney 
and muscle were wet ashed as described previously. Standard 
addition of known concentration of Fe, Zn and eu to samples 
were used to calculate percentage recoveries. 
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3.9 TISSUE ANALYSIS BY ATOMIC ABSORPTION SPECTROPHOTOMETRY 
(AAS) 
Cu, Fe and Zn levels of the heart, liver, muscle and kidney 
were determined by atomic absorption spectrophotometry. A 
Perkin-Elmer Model 2380 microprocessor controlled atomic 
absorption spectrophotometer (Perkin-Elmer Corporation, 
Norwalk, C.T., U.S.A.) was used. The results were expressed 
in microgram/gram (~g/g) wet weight. 
3.9.1 Principle of AAS 
Three types of photon-atom interactions form the basis of 
the three main branches of atomic spectroscopy, namely: 
atomic absorption spectroscopy (AAS) 
atomic emission spectroscopy (AES) and 
atomic fluorescence spectroscopy (AFS) 
All techniques require an atom cell, a monochromator, 
detector and readout. The differences lie in the light 
source and geometry. Briefly, AES does not require a light 
source. The other techniques require a light source but 
while in AAS the light must pass straight through the atom 
cell to the detector, in AFS the detector is placed at right 
angles to the light source. Trace element analysis was 
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performed by flame atomic absorption spectrophotometry in 
this study hence only the principle of atomic absorption 
will be discussed (Metcalf, 1987). 
In flame AAS a beam of radiation with a very narrow band 
width is produced by a radiation source (usually a hollow 
cathode lamp). Nebulization converts the sample which 
contains the element to be analysed, to a more amenable form 
for rapid atomization as follows: 
The sample is drawn up through a capillary tube at high 
velocity. The necessary suction is provided by using high 
flows of the oxidant gas (air) and the venturi effect. The 
high speed of the gas flow tends to break up the solution 
through turbulence as it emerges from the capillary tube. 
The nebulizer also functions as a mixing chamber for the 
sample, oxidant and the fuel. The flame created by the 
ignition of air-acetylene atomizes the liquid aerosol from 
the nebulizer (Metcalf, 1987). 
AAS measures the absorption of a beam of monochromatic light 
by atoms in a flame. The energy absorbed is proportional to 
the number of atoms present on the optical path. The 
external source emits the spectral line corresponding to the 
energy required for an electronic transition from the ground 
state to the excited state. Thus the electrons of an atom 
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move from its energy level in the ground state to an excited 
state. The energy of the electron is raised by the 
absorption of a discrete quantum of energy, exactly 
equivalent to that involved in transition. Before analysis 
of the absorbed 1 ight, a monochromator is necessary for 
isolation of the spectral line of interest before it reaches 
the detector (Williams and Wilson, 1984). 
The absorption of light in the atom results in a light 
intensity, 
amplifier. 
It' which is measured by the detector and 
The incident light intensity, 10, is the signal 
obtained when a blank sample is aspirated and the readout is 
adjusted to give 100% transmission (zero absorbance). When 
the sample containing the element to be analysed is 
aspirated the transmitted intensity is reduced. This 
reduction in intensity can be related to the concentration 
of the analyte (Metcalfe, 1987). 
3.9.2 Analytical Technique 
Procedures involved in set-up: 
The hollow cathode lamp was installed as specified by the 
instruction manual (Perkin Elmer, 1976b). The lamp current 
used was as specified on the lamp label. 
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The analytical wavelength, appropriate slit settings and 
other parameters are listed in table 1 (Perkin Elmer, 
1976a). 
------------------------------------------------------------
Element (nm) Slit 
setting 
Sensitivity Linear Working 


















Table 1 OPERATING PARAMETERS IN AAS 
The gain setting was used to optimise current. A warm-up 
period of about 10 minutes was allowed. Ignition of the 
flame followed. The primary support gas used was air and 
the fuel was acetylene. The tanks were equipped with 
pressure regulators which were checked regularly to see if 
the pressures were the same as set previously (namely 60 
psig for air; 70 psig for acetylene). A lean (oxidizing) 
air-acetylene mixture gives a blue hot flame. A rich 
(reducing air-acetylene) mixture gives a yellow cool flame. 
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Either the oxidant flow or fuel flow was adjusted to provide 
optimal flame conditions (a lean, oxidizing air-acetylene 
flame was used) . 
Calibration 
At least two dilutions of daily working standard for Cu, Fe, 
and Zn were prepared from certified atomic absorption 
standards (lOOo~g/ml Cu, Fe and Zn). The concentrations of 
standards used to establish linear standard curves daily 








The appropriate calibration standards were analysed after 5 
sample solutions as signals drifted over a period of time. 
Recalibration was performed if variations from the known 
concentrations were >5%. In the case of Fe, when the 
concentration range of the sample standard exceeded that of 
the sample a higher standard concentration was used. 
Before shut-down and before commencing analysis deionized 
water was aspirated for a few minutes. This was performed 
to remove contaminants. 
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The operating parameters that were used are listed as 
follows: 
Sample introduction rate 
Integration time 




3.9.3 optimizing Procedures 
The burner head was adjusted relative to the light path of 
the instrument to obtain maximum sensitivity. The nebulizer 
was adjusted for optimal sensitivity as specified by the 
operations manual (Perkin Elmer, 1976a) 
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3.10 STATISTICAL ANALYSIS 
The nonparametric u-test of Mann-Whitney was applied to test 
for significance of differences between the parameters 
analysed as this was ideally suited for the sample size. 
The Bonferroni correction for multiple comparisons was made 
when several groups were compared. All statistical analysis 
was performed in collaboration with the Institute of 




4.1 THE EFFECT OF VITAMIN B-6 DEFICIENCY ON FOOD INTAKE 
Experiment 1 
The data in table 2 shows the mean daily food consumption 
for each animal over the eight week period. During this 
period a significant difference was found to exist between 
the control group (group 1) and the deficient group (group 
3) (p<O,05). The food consumption of the marginally 
deficient group was also found to be significantly different 
from group 3 (p<O,05). 
Experiment 2 
The data on food consumption in both groups is given in 
table 3. The food consumption was significantly different 
between group 1 and group 3 (p<O,05). 
Food intake declined significantly (p<O,05) by the first 
week of study in the vitamin B-6 deficient group. They 
often left food in the food containers and, in comparison to 
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the vitamin B-6 adequate animals, virtually always ate 
slowly. In contrast the control animals almost invariably 
ingested all their food leaving very little in the food 
containers. 
The food consumption trends for each group in both 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3 EFFECT OF VITAMIN B-6 DEFICIENCY ON DAILY FOOD 
CONSUMPTION : Experiment 2 




































Data are presented as mean ±SD and were obtained from 12 rats per 
groups. Means for each week not followed by the same superscript 
letter are significantly different (P<O,025). Groups 1 and 3 were 
fed 3,5 and Omg/kg vitamin B-6 in the diet. Individual rat food 






























































































































































































































































4.2 THE EFFECT OF VITAMIN B-6 DEFICIENCY ON GROWTH 
Experiment 1 
The data on the mean percentage body mass gain of groups 1, 
2 and 3 are given in table 4. 
Percentage body mass gain was calculated as follows: 
Mean weekly animal mass (g) x 100 
mass of animal on day 0 
The percentage body mass gain of group 2 was not 
significantly different from group 3 (p>0,05). However a 
significant difference existed between groups 1 and 3 and 
groups 2 and 3 ,over the 8 week period (p<0.05). 
Figure 17 shows the growth curves of the three different 
groups. 
Experiment 2 
Data on the mean percentage body weight gain of the 3 groups 
are listed in table 5. At the start of the study, the 
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weights were similar in all three groups with the average 
initial weights being approximately 80g. 
However, by the 2nd week of the study, the B-6 deficient 
rats weighed significantly less than the control and 
remained lower throughout the rest of the study. A 
significant difference was observed between all three groups 
(p<O, 05) after the second week of study. The percentage 
weight gain of the pair-fed group was not significantly 
different from group 3 in week 6 (p>0,05). 
Figure 18 shows the growth curves of the three different 
groups. Growth patterns were similar for all groups for the 
first 4 weeks of dietary treatment. Group 1 and 2 showed a 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.3 PLASMA PL IN VITAMIN B-6 DEFICIENCY 
Experiment 1 
At the end of 8 weeks of dietary treatment blood was drawn 
and analysed for plasma PL levels. (Table 6 and 7) Using 
the u-test of Man-Whitney, there were significant 
differences between groups 1 and 2, 1 and 3 and 2 and 3 in 
both experiments 1 and 2 (p<0,05) 
Figure 19 shows the plasma PL levels in both experiments. 
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TABLE 6 THE EFFECT OF VITAMIN B-6 DEFICIENCY ON 
PLASMA PL LEVELS : EXPERIMENT 1 
-----------------------------
GROUP PLASMA PL (ngjml) 
-----------------------------
1 63,04 ±16,39a 
2 12,04 ± 5,29b 
3 2,71 ± 0,92 c 
Plasma PL values are given as means ± SD and were obtained 
from 11 rats in group 1 and 2 and 10 rats in group 3. Means 
for each group not followed by the same superscript letter 
are significantly different. (p<o, 05) . PL values were 
obtained at end of an eight week period following an 
overnight fast. Groups 1, 2 and 3 received 3,50; 1,75 and 
Omgjkg vitamin B-6 in the diet respectively. The two-tailed 
P values for groups 1 vs 2 , 1 vs 3 and 2 vs 3 were equal to 
0,0001. A significant different exists between groups when 
p<0,0167. 
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TABLE 7 EFFECT OF VITAMIN B-6 DEFICIENCY ON PLASMA PL 
LEVELS : EXPERIMENT 2 
GROUP PLASMA PL (ng/ml) 
1 51,32 ±12,42a 
2 22,87 
3 1,51 
Results (mean ±SD) were obtained from 12 rats per group 
at the end of 8 weeks. Means not followed by the same 
superscript letter are significantly different (p<0,05) 
Group 1 received 3,5mg vitamin B-6 per kg diet. 
Group 2 (pair-fed control) received 3,5mg/kg vitamin B-6 
in the diet. 
Group 3 received Omg/kg vitamin B-6 in diet. 
The two-tailed p-values for groups 1 vs 2, 1 vs 3 and 2 vs 3 
were equal to 0,0001. A significant difference exists 
between groups when p<0,0167. 
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4.4 TRACE ELEMENTS ANALYSIS 
The mean of the trace element levels of the various tissues 
of experiment 1 and experiment 2 are given in Tables 8,9 and 
10. 
Trace element concentration in ~g/g = Trace element concent-
ration in ~g/ml x 25 
(dilution factor) 
divided by weight of 
tissue 
The percentage recoveries of trace elements after digestion 




The individual values for each element in each tissue is 




The copper levels of the various tissues examined are 
summarized in table 8. 
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TABLE 8 : MEAN OF COPPER LEVELS IN TISSUES IN Uq/q WET WEIGHT 
Experiment 1 
------------------------------------------------------------------
GROUP LIVER ±SD KIDNEY ±SD HEART ±SD MUSCLE ±SD 
-------------------------------------------------------------------
1 4.28 ±0,83 8 5,72 ±o, 73 8 3,48 ±1,178 1,08 ±0,43
8 
-------------------------------------------------------------------
N 11 10 11 11 
-------------------------------------------------------------------
2 3,59 ±1,028 5,13 ±0,958 3,44 ±1,138 1,25 ±0,278 
-------------------------------------------------------------------




b 3,27 ±0,47 
11 
Experiment 2 
GROUP LIVER ±SD 
1 3,95 ±0,468 
N 12 
2 4,27 ±0,608 
N 12 
6,24 ±1,43 8 
9 
KIDNEY ±SD 







3,42 ±0,53 8 
11 





1,59 ±0,42 8 
12 
b 1,06 ±0,18 
12 
-------------------------------------------------------------------
3 3,73 ±1,178 3,99 ±0,198 3,72 ±0,718 b 0,78 ±0,26 
-------------------------------------------------------------------
N 12 12 12 12 
-------------------------------------------------------------------
Values are expressed as mean ±SD. N = no of rats per group. 
Values not followed by the same superscript letter are 
significantly different (P<0,05). In experiments 1 and 2, 
groups 1 and 3 received 3,5mg/kg and Omg/kg vitamin B-6 in the 
diet. Group 2 (experiment 1) received 1,75mg/kg vitamin B-6 in 
the diet. Group 2 (experiment 2) was the pair-fed control 
receiving 3, 5mg/kg vitamin B-6 in the diet. Figures for 
individual rats and P-values are given in Appendix 5. 
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Group 3 had a significantly lower liver eu content than 
group 1 (p<0,05). Group 3 eu content of kidney, heart and 
muscle were not significantly different from group 1 
(p>0,05). 
Group 2 tissue eu content were not significantly different 
from group 1 and 3 (p>0,05). 
Experiment 2 
Group 3 eu content of tissues were not significantly 
different from group 1 (p>0,05) except for muscle which was 
significantly reduced (p<0,05). 
Group 2 (pair-fed) eu content of tissues were not 
significantly different from group 1 (p>0,05) except for the 
heart which was significantly elevated and muscle which was 




The iron content of the various tissues examined are 
summarized in table 9. There were no s igni f icant 
differences in the liver, kidney, heart and muscle Fe 
content between group 1 and group 2 (p>0,05). 
A significant increase was observed in the liver and heart 
of group 3 when compared with group 1 and group 2 (p<0,05). 
A significant decrease in muscle Fe content was found in 
group 3 when compared to groups 1 and 2 (p<0,05). 
Liver Fe content was significantly higher in group 3 than 
group 2 (p<0.05). 
Experiment 2 
The data in table 9 indicate that the Fe content in the 
kidney of the pair-fed control group was significantly 
higher than the control group (group 1) (p<0,05). 
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The deficient group (group 3) had a significantly higher Fe 
content in the liver when compared to group 1 while the 
muscle Fe content was significantly decreased (p<0,05). No 
significant differences were observed in the kidney and 
heart between group 3 and group 1 (p<0,05). 
The Fe content of the liver, kidney and muscle of group 3 
were significantly different from the pair-fed group 
(p<O, 05) . 
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TABLE 9 : MEAN OF IRON LEVELS IN TISSUES IN "gIg WET WEIGHT 
Experiment 1 
GROUP LIVER ±SD KIDNEY ±SD HEART ±SD MUSCLE ±SD 
1 167,67 ±17,068 69,04 ±7,918 85,80 ±6,268 17,44 ±2,23 8 
N 11 11 11 11 
2 154,46 ±30,798 70,73 ±8,748 82,81 ±5,318 17,41 ±3,59 8 
N 11 11 11 11 
-------------------------------------------------------------------
3 295,99 ±55,36b 69,32 ±7,948 98,07 ±6,46b 9,65 ±1,43b 




GROUP LIVER ±SD KIDNEY ±SD HEART ±SD MUSCLE ±SD 
-------------------------------------------------------------------
1 177,92 ±32,588 55,52 ±5,708 73,22 ±13,378 14,49 ±1,818 
-------------------------------------------------------------------
N 12 12 12 12 
-------------------------------------------------------------------
2 166,45 ±21,758 85,14 ±25,54b 86,83 ±17,528 14,66 ±2,03 8 
-------------------------------------------------------------------
N 12 11 12 12 
-------------------------------------------------------------------
3 316,59 ±31,85b 62,42 ± 8,598 77,98 ± 4,808 11,14 ±1,57b 
-------------------------------------------------------------------
N 12 12 12 12 
-------------------------------------------------------------------
Results are expressed as mean +SD. N=no of animals used. Values 
not followed by the same superscript letter are significantly 
different (P<O,05). In experiments 1 and 2, groups 1 and 3 
received 3,5 and O,mg/kg vitamin B-6 in the diet. In experiment 
1, group 2 received 1,75mg/kg of vitamin B-6 in the diet. In 
experiment 2, group 2 which was pair-fed with the deficient 
rats, recieved 3,5mg of vitamin B-6 in the diet. Figures for 




From table 10 Zn content of the liver, kidney, heart and 
muscle of group 1 was not significantly different from group 
3 (p>0,05). Zn levels of all tissues when not significantly 
different when group 2 was compared to group 3 (p>0,05). 
Experiment 2 
The Zn content of the liver, kidney, heart and muscle of 
group 1 was not significantly different from 3 (p>0,05). 
Group 1 Zn levels were not significantly different from the 
pair-fed group (p>0.05). Group 2 Zn tissue levels were not 
significantly different from group 3 (p>0.05). 
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TABLE 10 : MEAN OF TISSUE Zn LEVELS IN "gIg WET WEIGHT 
Experiment 1 
-------------------------------------------------------------------
GROUP LIVER ±SD KIDNEY ±SD HEART ±SD MUSCLE ±SD 
-------------------------------------------------------------------
1 32,58 ±1,70a 31,41 ±2,96a 20,12 ±5,34a 9,00 ±2,14a 
-------------------------------------------------------------------
N 11 11 11 11 
-------------------------------------------------------------------
2 32,78 ±1,98a 35,07 ±7,85a 19,12 ±5,01a 11,67 ±1,50a 
-------------------------------------------------------------------
N 11 11 10 11 
-------------------------------------------------------------------
3 32,75 ±3,48a 31,50 ±1,79a 26,26 ±8,73 a 11,21 ±2,15a 
N 11 11 10 10 
Experiment 2 
GROUP LIVER ±SD KIDNEY ±SD HEART ±SD MUSCLE ±SD 
1 30,61 ±1,97a 24,18 ±4,11a 17,99 ±3,51a 9,50 ±2,32a 
N 12 12 11 12 
2 32,44 ±1,99a 23,21 ±2,49a 18,99 ±1,08a 8,73 ±1,62a 
N 12 12 12 12 
3 30,95 ±1,94a 26,36 ±5,74a 18,97 ±0,99a 9,50 ±1,97a 
N 12 12 11 1 
-------------------------------------------------------------------
Values are expressed as means ±SD. N = number of animals used. 
Means not followed by the same supescript letter are 
significantly different (P<0.05). In experiment 1, groups 1, 2 
and 3 received 3,5; 1,75 and Omg/kg vitamin B-6 in the diet 
respectively. In experiment 2, groups 1 and 3 recieved 3,5 and 
Omg/kg vitamin B-6 in the diet, group 2 was the pair-fed 





5.1 APPEARANCE OF RATS 
Deficient animals in both experiments developed variable 
degrees of vitamin B-6 deficiency symptoms. All deficient 
animals developed an unkempt fur appearance compared to the 
controls. Around the 4th week some deficient animals 
developed acrodynia. 
5.2 FOOD CONSUMPTION AND GROWTH 
Experiment 1 
In this series group 1 received approximately 42J,.Lg/d of 
PN.HCl while group 2 received 21J,.Lg/d of PN.HC1. Despite the 
differences in PN.HCl intake/day no significant difference 
(p>O,05) in growth was observed between group 1 (control) 
and group 2 (marginally deficient). This finding supports 
earlier reports that 24J,.Lg/d (van den Berg et al, 1982) and 
29J,.Lg/d (Lumeng et al, 1978) of vitamin B-6 were sufficient 
for maintaining maximal growth of the rat. 
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The food consumption of groups 1 and 2 were approximately 
13-14 g/d as compared to the consumption of approximately 
8g/d in group 3. 
Hence it can be concluded that growth and food consumption 
are not affected during a marginal deficiency of vitamin 
B-6. 
Experiment 2 
The vitamin B-6 deficient group (group 3) ate approximately 
9g of diet per day while the vitamin B-6 adequate group 
(group 1) consumed almost twice the amount; approximately 
16g per day. It was found that group 2 animals (pair-fed) 
which were fed the control diet usually quickly ate all the 
food offered to them. However, the vitamin B-6 deficient 
group often ate slowly and reduced their food intake after 
the first week. This suggests that either vitamin B-6 
deficiency induces anorexia or that a diet deficient in 
vitamin B-6 may be less palatable to a rat. 
The growth rates of group 1 was found to be significantly 
different from group 2 and group 3 (p<O,05). 
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In this study group 1 took in approximately 58~g/d of PN.HCl 
while the group 2 animals took in approximately 32~g/d of 
PN.HCl. The significant difference in growth rate between 
group 1 and 2 is due not only to the different intakes of PN 
but also probably due to restricted calorie intake, where 
deficiencies of other nutrients also play a role. 
The percentage body mass gained was found significantly 
different between group 2 and 3 except in the 1st and 6th 
week. (p<0,05). 
Hence, it can be concluded that the reduced weight gain of 
the deficient group could not have solely resulted from 
lower food intake because group 2 consumed the same quantity 
of food. 
From the above discussion of growth rates in both 
experiments it was found that although the pair-fed group 
consumed 32~g/d of PN. HCl this was not sufficient to 
maintain maximal growth. However, the group receiving 
21~g/d of PN.HCl showed no significant difference in growth 
when compared to the control (p<o, 05) . Thus it can be 
concluded that lower intakes of vitamin B-6 will only result 
in maximal growth if deficiencies of other nutrients do not 
exist. 
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5.3. PLASMA PL LEVELS 
Plasma samples drawn at the end of eight weeks were analysed 
for PL using a method described by Ubbink et al (1985, 
1986) . Several methods based on HPLC have been described 
but were unsuitable for routine measurement of blood levels 
and suffered from the disadvantage that analysis had to be 
carried out in a specially equipped darkroom. Ubbink et aI, 
1985 developed a method whereby the semicarbazone PL 
derivatives were stable enough to allow analysis to be 
carried out in under normal light and temperature. 
In both experiments deficient groups were found to have a 
significantly lower PL level (p<O,05) than groups 1 and 2. 
Although the pair-fed group's PL levels were much lower than 
the control group, they had a considerably higher level than 
the deficient group. This indicates that restricted feed 
does have an effect on lowering the level of PLo 
5.4 COPPER CONTENT OF TISSUES 
Abnormal copper metabolism was noted in the vitamin B-6 
deficient rats. Al though the liver and muscle Cu were 
significantly lower in group 3 than controls in experiments 1 




however, this did not achieve statistical 
Although group 3 consumed less food and deionized water than 
group 1 the reduction in copper is not likely to be an effect of 
a decreased dietary supply. This is due to the fact that the 
pair-fed control group took in the same amount of trace elements 
but had higher Cu levels than Group 3. However pair-feeding did 
result in an increase in heart copper levels. 
Data on the effect of vitamin B-6 on Cu metabolism has been 
lacking. However, it is well established that several cu 
metalloenzymes need PLP as a cofactor ego the amine oxidases of 
the liver which contain firmly bound PLP are copper proteins. 
(Gray and Daniel, 1973) The possiblity of decreased Cu content 
being a reflection of changed activity of special Cu dependent 
proteins in vitamin B-6 deficiency cannot be totally ruled out. 
A more plausible explanation for the present findings may be the 
observations of Channa, 1988. It was found that vitamin B-6 
deficient rats exhibited a significantly greater rise in eu 
excretion than control and marginally deficient rats in a 
balance study. 
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A significantly greater rise in Zn excretion was also noticed in 
vitamin B-6 deficient rats than in the control. 
excretion of cu was attributed to two factors: 
The increased 
i) the decreased availability of picolinic acid in vitamin B-6 
deficiency. Evans and Johnson, 1980 reported that Cu has a high 
association constant with picolinic acid. Thus, in addition to 
its postulated role in zinc absorption it may also have an 
effect on Cu absorption. 
ii) The mutual antagonism of Cu and Zn. Channa, 1988 also found 
a greater excretion of zinc in vitamin B-6 deficiency. The high 
intraluminal content of Zn may have inhibited the absorption of 
Cu (Channa, 1988). This phenomenon has been widely reported. 
This type of interaction may resul t in lower copper 
concentrations in various organs. 
It is also possible that more Cu was utilized for ceruloplasmin 
synthesis due to the need for iron mobilization. But this is 
not likely as elevated Fe stores were observed. 
Liver copper concentrations in the fetus and newborn is 
physiologically elevated and declines during maturation. 
(Versieck, 1985) It is possible that the normal process of 
mobilization of hepatic copper concentration which occurs during 
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maturation is augmented during pyridoxine deficiency. This 
would obviously lead to a further reduction in liver copper 
content. 
5.5 IRON CONTENT OF TISSUES 
vitamin B-6 deficient rats were observed to have elevated liver 
and heart Fe levels compared to rats receiving adequate PN.HCI 
(3,5mg/kg vitamin B-6 in diet) and marginally deficient rats 
(1,75mg/kg vitamin B-6 in diet). Deficient rats were shown have 
a statistically significant reduction in muscle Fe content than 
control and marginally deficient rats . 
Similar observations have been reported by Kirksey et aI, 1967 
and Ikeda et aI, 1979. They found elevated levels of Fe in 
liver and kidney of pyridoxine deficient rats. However, the 
reduction in muscle Fe has not been previously reported. 
Elevated Fe content in liver could not be attributed to 
differences in food intake . The liver Fe content of the 
pair-fed group receiving the same amount of food as the 
deficient group, was significantly different from the deficient 
rats. However, pair-feeding did result in significantly 
increased kidney Fe content. The reasons underlying the change 
in the Fe metabolism during pair-feeding is not known. However, 
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it is well known that the type of feeding pattern adopted by 
control animals, known as meal eating, results in a number of 
anatomical, biochemical and physiological modifications. While 
other animals were given food ad libitum, pair-fed animals eat 
their food rapidly leaving empty trays and starved for the 
remainder of the day. possible mechanisms underlying changes in 
trace element metabolism caused through pair-feeding will not be 
deal t with in this study. The introduction of the pair-fed 
group in the second study was to distinguish between changes 
arising solely from decreased food consumption and those 
directly related to pyridoxine deficiency. However, it is 
possible that once Fe stores were repleted excess Fe may have 
been excreted via the kidneys in the pair-fed group. This could 
partially explain the increased Fe noted in the kidneys. In 
experiment 2 a similar trend was noted in the deficient group 
but this did not achieve statistical significance. 
Generally, it is clear pyridoxine deficiency has led to 
elevation of liver Fe stores and a reduction in muscle Fe 
stores. Mechanisms underlying these changes are not tenable as 
several other metabol ic pathways and parameters have to be 
tested to confirm these hypotheses. 
The liver serves an important function in the maintenance of 
whole body iron homeostasis through it roles as a major storage 
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organ for Fe and is the principal site for transferrin synthesis 
(Bacon and Tavill, 1984). Its central role in Fe metabolism 
makes it a reliable means for assessing Fe status. Transferrin 
synthesised by the hepatocytes delivers Fe to storage sites and 
sites of utilization predominantly muscle and liver (Bacon and 
Tavill, 1984). 
possible mechanical leading to changes of the tissue Fe in 
vitamin B-6 deficiency are outlined. 
1. Underwood, 1971 reported that young animals are more 
susceptible to loss of myoglobin than mature animals. Also 
skeletal muscle appears to be more susceptible to this loss than 
cardiac or diaphragmatic muscle . Because young animals were 
used in this study and no Fe reduction in other tissues were 
observed it is possible that a loss of myoglobin from muscle 
occurred. It is possible that Fe from muscle was mobilized 
during pyridoxine deficiency-induced abnormal Fe metabolism. 
This however only explains the decline in Fe content. Further 
research is needed to explain the mechanism and biological 
significance of the differences in Fe metabolism during vitamin 
B-6 deficiencies. 
2. The elevation of 1 i ver Fe content in group 3 is 
interesting. Considerable evidence seems to indicate the 
existence of an sideroblastic anemia in the deficient state. 
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Sideroblastic anemia is characterised as having varing numbers 
of hypochromic, microcytic red cells in the blood. Increased Fe 
stores in the reticulo-endothelial system and in parenchymatous 
organs such as the heart, pancreas and liver is found. Serum 
cholestrol is raised and Fe binding protein is saturated 
(Housten, 1985). Kinetic studies show increased Fe turnover but 
impaired Fe utilization. 
While a pyridoxine free diet fed to dogs led to a hypochromic 
sideroblastic anemia (Prasad, 1978) no such reports have been 
made concerning rats. In man, pyridoxine responsive anemias 
were originally classified as sideroblatic. The response may be 
due to PN supplementation. PN supplementation prevented the 
inhibition of hemoglobin synthesis by PL-Fe complexes caused by 
increased Fe stores at the site of Hb synthesis (Bishop and 
Bethel, 1959). Not all cases cited are responsive to therapy. 
However, Kirksey and Tabacchi, 1967 reported increased liver Fe 
stores. However, no mention was made a sideroblastic anemia. 
Although Hb content was not significantly altered; polycythemia, 
lower mean corpuscular Hb and mean corpuscular volume was found. 
Several instances have been reported of polycythemia vera 
associated with sideroblastic anemia (Prasad, 1978). Thus 
pyridoxine deficiency may have resulted in a sideroblastic 
anemia. 
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Thus it is possible that a dietary deficiency of pyridoxine 
would lead to a sideroblastic anemia due to decreased 
availability of PLP. The synthesis of hemoglobin is dependent 
on PLP. At a very early stage in the synthetic pathway PLP is 
needed for the formation of succinyl-CoA and -aminolevulinic 
acid. Hence hematopoiesis will be affected by the lack of PLP. 
If hemoglobin synthesis is impaired less Fe will be incorporated 
into protoporhyrin to form heme in the final biosynthetic step 
Fe metabolism will be affected resulting in increased Fe storage 
in certain tissues. The high proportion of Fe present in Hb 
indicates that any condition influencing the level of Hb in the 
blood will greatly affect the Fe status of the body. 
3) Thus increased Fe stores is due to less Fe being 
incorporated into hemoglobin due to the lack of PLP. This 
increased Fe may have been augmented or caused by the decrease 
of Cu observed in the present study. The possibility is very 
likely as a considerable elevation in liver Fe was observed. 
Dietary deficiencies or excesses of some micronutrients create 
secondary disorders in tissue levels of other micronutrients 
(Sherman and Tissue, 1981). The interaction of eu and Fe 
illustrates this point very well. Cu is transported to the liver 
were is is incorporated in ceruloplasmin. Ceruloplasmin links 
the Cu and Fe metabolism, an interaction causing the occurrence 
of anemia in the case of Cu deficiency. As a ferroxidase, 
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ceruloplasmin catalyses the conversion of Fe from the ferrous 
to ferric state before Fe is transported from the liver for 
hemoglobin synthesis. The postulated anemic state and 
increased liver Fe found in copper deficiency may be attributed 
to inadequate ceruloplasmin for the moblilization of Fe from the 
liver (fig.19) (Peereboom, 1985). 
Thus in addition to the effect of PLP, decreased levels of Cu 
may impair moblization of Fe resulting in increased Fe stores. 
STORAGE MOBILISATION-RECYCLING TRANSPORT 
~erroxidase 
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Fig. 19 : THE CENTRAL ROLE OF CERULOPLASMIN (Ferroxidase) IN 
LINKING Cu AND Fe METABOLISM (Peereboom, 1985) 
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5.6 ZINC CONTENT OF TISSUES 
There were no significant differences of zinc levels of tissues 
between the groups studied. 
Thus far reports on the effect of vitamin B-6 deficiency on zinc 
uptake (Prasad, et aI, 1982), tissue levels of zinc (Hsu, 1965; 
Gershoff, 1968) and zinc excretion (Channa, 1988) strongly point 
to the fact that the nutritional status of zinc may be related 
to vitamin B-6 status. In addition many symptoms of zinc 
deficiency and vitamin B-6 deficency are similar such as food 
intake, growth, dermatolog ic lesions and impaired immune 
function (Brown, 1981). Thus it is quite surprising that no 
significant change was noticed in zinc tissue levels if viewed 
in this light. 
In addition to the above observations, the role of picolinic 
acid, a tryptophan metabolite, in zinc metabolism postulated by 
Evans, 1980 is debatable. A ligand, thought to originate from 
the pancreas was found in the intestinal wall and in the milk of 
certain species (Evans, 1980, Hurley and Lonnerdal, 1980). Its 
identity is still uncertain, although it is claimed to be 
protaglandin, citrate (Hurley and Lonnerdal, 1980) or picolinic 
acid (Evans, 1980). Picolinic acid enhances the absorption of 
zinc (Evans, 1980) but this property is shared by many other 
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chelating agents. It would be surprising if the effects of 
picolinic acid were unique when many other ligands are also 
present in the intestinal mucosa. Thus Evans' proposal that 
vitamin B-6 deficiency would result in decreased picolinic acid 
production leading to a malabsorption of zinc is debatable. 
Regardless of whether picolinic acid plays a role in zinc 
uptake, other studies cited in the literature raise the 
intersting possibility of an interaction between Zn and vitamin 
B-6. The fact that this study failed to confirm this 
relationship is not surprising if one takes into account the 
fact that tissue levels were used to assess zinc status. 
The use of tissue levels in defining Zn status could be 
misleading (Golden, 1989). He proposed the existence of 2 types 
of nutritional deficiencies based on the response of the tissue 
levels. While the type 1 nutrient deficiency leads to a 
reduction in tissue concentration; type 11 nutrient deficency 
does not. Zn falls into the latter category. So if a Zn 
deficiency does exist as Channa' s results will tempt one to 
believe, it would be very difficult to diagnose by analysing 
trace element content of the tissues. 
According to Golden, 1989 if the animal is at a stage of 
development where sensitivity to zinc is high it stops growing, 
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without a reduetion in tissue concentration when given a diet 
that is low in zinc. He proposed that Zn is locked in tissues 
and is fundamental to the composition, integrity and day-to-day 
functioning of that tissue. Zinc would only be released if 
whole tissue is catabolized or small amounts are released if 
there is metabol ic re-adj ustment. These metabol ic re-
adjustments are proportionately small and totally unrelated to 
the zinc deficiency. 
If whole tissue is being broken down and the excess nutrient 
liberated will have to be metabolized or excreted. This is one 
of the possible explanations for Channa I s observation of 
increased zinc excretion. 
The fact that zinc deficiency is characterized by a large fixed 
pool in the tissues makes analysis of zinc status using tissue 
content misleading. If a deficiency does exist analysis of the 
small, rapidly turning over free pool would be valid as this 
pool would be sensitive to zinc deficiency. Hence plasma or 
serum should be used. But use of plasma or serum to diagnose 
zinc deficiency is invalid as it does not reflect total body 
zinc and is subject to metabolic alteration. Anyway, according 
to the latest paper quoted on diagnosis of zinc deficiency, 
total body zinc bears a questionable relationship to zinc status 
as it is not a type I nutrient deficiency (Golden, 1989). 
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The latest research on the zinc diagnostic problem has 
recommended the assay of plasma zinc and red blood cell 
metallothionein-1 to diagnose zinc deficiency (Golden, 1989). 
Thus in conclusion, the failure to show a reduction in tissue 
zinc levels in this study is due to the fact that a zinc 
deficiency is a type II nutrient deficiency. Also the failure 
to indicate significantly increased zinc levels in tissue 
supports results obtained in this laboratory by Channa. 
Thus tissue zinc remains constant over a wide range of Zn 
intakes, indicating that there is efficent homeostatic control 




The results of this study indicate that the lower levels of 
vitamin B-6 cited in the literature do not support maximal 
growth of the rat during restricted feeding. However, maximal 
growth is maintained at the lower levels of the vitamin when 
deficiencies of other nutrients do not exist. 
This study shown that vitamin B-6 metabolism related to trace 
element status. It is clear that an alteration of Fe metabolism 
exists in vitamin B-6 deficiency. Elevated Fe stores in the 
liver and heart coud be due to the existence of a sideroblastic 
anemia during pyridoxine deficiency. The decreased muscle 
stores may have been due to a loss of myoglobin. The liver and 
muscle copper content was found to be lowered in pyridoxine 
deficiency. Thus its role in iron metabolism may have been 
impaired resulting in further elevation or iron stores. various 
parameters have to be tested before the symptoms of the 
sideroblastic anemia can be confirmed. 
Failure to show a link between zinc status and vitamin B-6 
metabolism confirms the report by Golden, 1989 that the 
measurement of tissue levels is an invalid indicator of zinc 
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status. This is based on the assumption that zinc deficiency 
exists during a vitamin B-6 deficiency. As mentioned earlier 
considerable evidence points to this belief. It is therefore 
recommended that a valid assessment of zinc status such as 
measurement of plasma zinc or metallothionein -1 in red blood 
cells be carried out to shed more light on the issue. 
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Summary 
All previous studies on the relationship between vitamin B-6 and 
trace element metabolism point strongly to possible link between 
the two micronutrients. They function as catalysts in a wide 
variety of reactions and thus have common pathways. This study 
was designed to examine the effects of graded levels of vitamin 
B-6 on tissue trace element levels. In the first experiment 33 
young male wistar rats were divided into three groups of 11 rats 
each. Group 1 the vitamin B-6 adequate group received 3,5 mgjkg 
PN Hel. Group 2 a marginally deficient group received 
1,75mgjkg of vitamin B-6 in the diet. Group 3 the deficient 
group received 0 mgjkg of vitamin B-6 in the diet. In a 
separate experiment 36 young male wistar rats were divided into 
3 groups and subjected to the same dietary treatments except 
that the group 2, was replaced by a pair-fed control group. 
Plasma PL levels were analysed to determine the vitamin B-6 
status of the animals. Tissue trace elements were assayed by 
atomic absorption spectrophotometry in tissue samples obtained 
from the study. 
The growth rates and food consumption was significantly 
different in all groups except group 1 and 2 in experiment 1 
indicating that these two factors are not altered during a 
133 
marginal deficiency. However, it was found that a lower intake 
of vitamin B-6 during restricted feeding does impair growth. 
Growth rate and food consumption of the deficient group was 
decreased when compared to the marginally deficient and control 
groups. The plasma PL levels were significantly different in 
all three groups in both series. 
from group 1 to group 3 was found. 
A progressive decrease in PL 
No significant changes were found in zinc tissue levels. This 
contributed to the assessment of Zn in tissues as being invalid. 
Elevated liver and heart Fe levels found in Group 3 may be 
attributed to impaired mobilization, defective hematopiesis and 
the possible existence of an anemic state. Increased eu 
excretion may have led to decreased in muscle and heart eu 
levels observed. This study showed that Fe and eu status were 
affected by the vitamin B-6 deficiency. 
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APPENDIX 1 FOOD CONSUMPTION : MEAN DAILY INDIVIDUAL FOOD 
CONSUMPTION (q) OVER 8 WEEKS : Experiment 1 
-------------------------------------------------------------------
GRP NO. WK 1 WK 2 WK 3 WK 4 WK 5 WK 6 WK 7 WK 8 
-------------------------------------------------------------------
1 1 10,4 10,2 10,3 10,9 12,7 11,7 12,2 12,9 
2 11,6 13,0 13,2 10,8 11,9 14,0 14,3 12,8 
3 10,0 11,2 11,9 11,1 13,9 13,9 14,4 13,0 
4 15,0 17,4 17,2 12,7 14,1 17,8 20,5 18,6 
5 12,7 14,3 14,8 12,9 15,1 17,6 16,1 16,2 
6 13,4 16,1 14,9 12,4 13,4 17,1 16,3 15,7 
7 10,7 11,2 11,4 10,4 12,1 13,0 14,6 12,7 
8 12,4 14,0 13,7 12,7 12,0 15,1 13,5 12,9 
9 13,0 13,5 13,7 13,1 13,8 16,6 16,6 15,1 
10 12,8 13,6 10,2 11,2 10,1 12,8 14,0 12,8 
11 14,1 15,3 14,7 13,8 14,1 15,7 15,5 15,7 
2 1 13,1 12,7 13,5 12,4 12,9 13,3 13,7 13,3 
2 12,1 13,4 11,2 10,8 11,9 13,2 10,7 14,1 
3 10,4 11,0 10,3 9,1 11,8 12,0 11,7 12,6 
4 10,3 11,8 11,7 10,3 11,9 12,4 12,4 12,4 
5 12,9 14,2 15,1 13,9 12,9 15,8 15,5 14,6 
6 12,0 11,7 11,8 13,1 13,2 13,3 12,3 13,9 
7 13,7 15,1 13,5 12,1 13,5 14,6 15,3 14,9 
8 12,5 12,6 13,7 12,3 12,2 13,1 13,7 12,7 
9 12,6 13,5 13,8 13,6 11,8 14,1 14,7 14,4 
10 14,3 16,4 15,4 11,9 12,4 14,3 16,5 13,9 
11 14,6 14,9 13,5 13,9 15,6 15,7 14,2 13,1 
3 1 9,9 8,6 7,7 7,9 7,7 7,0 8,8 8,0 
2 11,7 7,4 8,8 7,6 8,6 7,0 6,7 5,9 
3 9,7 6,7 5,9 7,2 5,9 6,1 6,6 5,2 
4 8,2 8,7 8,1 8,7 8,3 6,3 7,8 6,9 
5 10,3 8,9 8,7 7,8 6,7 6,3 6,4 6,8 
6 8,5 7,8 7,2 7,4 6,8 6,7 6,1 6,5 
7 10,2 8,3 8,8 6,1 8,8 6,6 9,7 9,6 
8 11,6 10,2 8,7 7,9 8,3 6,0 8,2 4,8 
9 11,6 7,2 8,2 8,8 9,2 7,9 10,1 8,1 
10 9,7 7,7 7,8 7,9 5,8 7,8 6,9 6,8 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX 3 GROWTH : WEEKLY INDIVIDUAL ANIMAL MASS (g) 
Experiment 1 
-------------------------------------------------------
GRP NO. DAY 0 WK 1 WK 2 WK 3 WK 4 WK 5 WK 6 WK 7 WK 8 
-------------------------------------------------------
1 1 76 123 154 180 197 213 236 264 280 
2 78 134 177 204 219 236 269 276 286 
3 84 123 165 194 214 234 259 278 286 
4 96 168 220 259 276 300 332 372 392 
5 88 146 190 226 247 276 306 316 338 
6 86 150 200 234 244 270 310 336 360 
7 78 130 164 194 212 232 256 272 290 
8 88 144 190 218 240 258 282 296 308 
9 99 158 200 232 256 276 300 319 329 
10 94 144 175 192 210 220 236 257 266 
11 92 155 198 228 257 278 298 318 330 
2 1 98 150 188 222 240 266 284 302 315 
2 100 148 186 228 226 250 269 292 304 
3 76 123 158 175 195 217 227 246 262 
4 82 126 160 179 202 218 244 265 277 
5 100 156 202 236 269 296 319 340 358 
6 80 137 169 200 225 242 264 282 298 
7 102 158 200 228 257 280 298 318 331 
8 102 148 185 218 232 244 268 284 290 
9 98 155 201 228 258 280 302 324 336 
10 97 162 208 234 248 274 298 317 326 
11 79 142 183 213 238 264 286 298 306 
3 1 90 125 140 148 154 150 151 158 163 
2 96 140 162 173 178 184 178 173 166 
3 82 120 124 132 138 139 134 138 132 
4 86 116 138 150 157 158 152 152 155 
5 84 124 140 150 154 150 150 151 154 
6 80 110 122 130 134 132 134 136 136 
7 84 136 148 157 162 164 171 177 182 
8 90 137 160 160 168 175 169 174 153 
9 95 131 137 144 152 154 154 154 155 
10 79 118 131 140 144 136 144 146 143 




















































































































































































































































































































































































































































































































































































































APPENDIX 4 GROWTH: WEEKLY INDIVIDUAL ANIMAL MASS (g) 
Experiment 2 
------------------------------------------------------------
GRP NO. DAY 0 WK 1 WK 2 WK 3 WK 4 WK 5 WK 6 WK 7 WK 8 
------------------------------------------------------------
1 1 70 120 160 195 245 285 310 340 363 
2 95 155 200 230 270 303 327 346 362 
3 80 125 160 205 255 290 323 352 373 
4 90 155 200 240 293 321 343 355 374 
5 85 150 200 240 281 314 321 349 345 
6 80 155 200 250 304 339 367 388 409 
7 85 150 200 235 280 305 312 327 340 
8 90 145 200 235 272 302 325 345 357 
9 70 120 160 195 243 282 311 330 351 
10 70 120 160 185 217 236 264 281 283 
11 70 125 160 200 258 297 327 357 382 
12 80 125 160 185 227 256 289 320 342 
2 1 80 129 142 168 174 178 174 188 197 
2 80 126 146 166 177 186 184 198 208 
3 85 135 149 178 193 206 199 213 221 
4 75 127 149 176 188 198 192 214 228 
5 80 123 150 179 192 201 196 205 209 
6 85 136 155 184 191 194 188 203 211 
7 80 124 140 169 176 185 183 197 206 
8 90 133 157 188 203 212 203 212 224 
9 80 133 155 182 207 179 207 223 235 
10 75 125 149 180 193 201 196 205 215 
11 70 124 152 175 187 182 193 209 214 
12 85 120 150 173 187 189 195 208 213 
3 1 70 112 130 139 146 134 132 135 142 
2 70 120 145 152 170 145 152 155 151 
3 75 118 129 141 144 186 191 200 219 
4 85 145 165 164 173 167 172 173 180 
5 90 145 165 178 191 200 208 212 216 
6 80 119 145 162 174 149 148 166 172 
7 75 140 165 176 168 158 177 181 178 
8 90 129 145 150 159 179 192 190 189 
9 75 120 145 150 154 156 159 157 152 
10 75 130 155 161 168 180 182 192 195 
11 70 120 140 136 147 153 161 156 159 














































































































































































































































































































































































































































































APPENDIX 5 TISSUE LEVELS OF CU IN GROUPS FED VARYING LEVELS OF 





















1 4,83 4,69 5,97 3,96 3,38 3,99 
2 6,21 6,92 4,50 4,50 4,98 3,95 
3 6,45 4,50 4,84 5,38 3,94 
4 6,23 4,35 5,18 4,44 5,50 4,43 
5 5,91 4,24 5,98 5,50 3,90 
6 6,50 5,34 6,86 4,38 3,84 3,82 
7 4,43 5,32 3,85 4,35 3,95 
8 6,18 6,93 5,93 4,28 4,31 3,87 
9 5,93 5,01 6,96 5,38 3,91 3,91 
10 4,99 4,46 6,29 4,39 5,36 3,84 
11 (; ,00 4,91 3,41 5,47 4,32 
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APPENDIX 5 : TISSUE LEVELS OF Cu IN GROUPS FED VARYING LEVELS OF 





















1 3,17 4.38 4,34 2,96 4,91 3,56 
2 2,97 3,01 4,96 4,00 5,10 5,59 
3 5,19 3,00 4,72 3,01 5,25 2,95 
4 6,00 4,01 5,53 3,44 3,97 3,80 
5 2,35 2,35 6,50 4,34 3,58 2,96 
6 2,45 5,5 6,34 5,01 3,35 
7 3,50 3,81 2,92 3,42 4,40 4,41 
8 2,38 3,01 5,79 3,85 4,35 3,38 
9 3,37 3,88 8,26 2,93 3,87 3,63 
10 3,98 1,45 2,98 3,91 3,91 3,39 
11 2,88 2,25 2,88 3,92 3,72 
12 2,88 4,46 3,95 
-----------------------------------------------------------------
TISSUE LEVELS OF Cu IN GROUPS FED VARYING LEVELS OF 


































































1,00 1,00 1,00 
1,95 1,46 0,98 
1,48 1,00 0,99 
1,48 0,99 0,97 
1,96 0,97 0,48 
0,96 0,96 1,00 
1,94 1,00 0,98 
2,43 1,00 0,49 
0,99 0,99 0,50 
1,45 0,98 0,49 
1,48 0,98 0,98 




Two-tail P values for table 8. Cu content of the 
liver, kidney, heart and muscle 
Experiment 1 
----------------------------------------------
GROUP LIVER KIDNEY HEART MUSCLE 
----------------------------------------------
1 vs 2 0,1147 0,7032 0,7512 0,2749 
----------------------------------------------
1 vs 3 0,0043 0,8602 0,0613 0,5089 
----------------------------------------------
2 vs 3 0,4690 0,5320 0,0760 0,0480 
----------------------------------------------
Experiment 2 
GROUP LIVER KIDNEY HEART MUSCLE 
1 vs 2 0,2975 0,7073 0,0012 0,0023 
1 vs 3 0,3698 0,0732 0,3719 0,0003 
2 vs 3 0,1748 0,1185 0,0079 0,0177 
A significant difference exists between groups 
if the P value is < 0,0167 (0,05) 
3 
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APPENDIX 6 TISSUE LEVELS OF Fe IN GROUPS FED VARYING LEVELS OF 





















1 153,7 141,41 229,08 215,95 171,90 295,05 
2 160,5 138,18 250,03 120,52 166,35 301,25 
3 165,85 105,68 427,88 189,30 162,85 335,88 
4 175,80 118,24 255,00 204,06 149,80 312,50 
5 175,80 204,01 265,29 140,06 138,17 347,12 
6 189,52 156,67 291,58 208,00 162,05 196,07 
7 153,47 145,58 324,35 159,58 163,29 290,11 
8 152,67 159,06 174,72 166,19 168,63 262,18 
9 175,80 163,03 289,46 196,98 180,19 377,42 
10 142,5 206,18 347,91 209,66 140,32 351,55 
11 198,1 160,99 300,57 135,38 217,71 306,91 
12 189,30 186,18 323,10 
------------------------------------------------------------------
TISSUE LEVELS OF Fe IN GROUPS FED VARYING LEVELS OF 
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Two-tail P values for Table 9 




GROUP LIVER KIDNEY HEART MUSCLE 
----------------------------------------------
1 vs 2 0,1999 0,5993 0,1783 0,7676 
1 vs 3 0,0001 0,9738 0,0007 0,0001 
2 vs 3 0,0001 0,5767 0,0003 0,0001 
Experiment 2 
GROUP LIVER KIDNEY HEART MUSCLE 
1 vs 2 0,3555 0,0006 0,0735 0,8172 
1 vs 3 0,0000 0,0376 0,3556 0,001* 
2 vs 3 0,0001 0,0074 0,1842 0,0007 
----------------------------------------------
A significant difference exists between groups 
if the P value is < 0,0167 (0.05) 
3 
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APPENDIX 7 TISSUE LEVELS OF Zn IN GROUPS FED VARYING LEVELS OF 





















1 33,56 32,82 36,35 27,72 32,42 31,98 
2 33,00 35,16 35,00 32,51 31,43 34,95 
3 31,50 32,78 27,88 33,37 35,86 32,92 
4 33,58 31,37 34,00 29,50 33,89 32,42 
5 31,80 31,80 35,78 30,59 33,30 28,37 
6 28,57 30,62 30,83 28,00 33,94 30,27 
7 33,17 31,12 32,44 29,64 30,46 30,17 
8 34,59 37,45 38,64 31,13 33,33 31,68 
9 32,35 32,16 29,44 30,16 32,46 30,10 
10 35,00 32,10 31,31 33,86 33,60 28,01 
11 31,73 33,33 28,62 30,63 29,35 30,27 
12 31,19 29,27 30,27 
-----------------------------------------------------------------
APPENDIX 7 CONTINUED 
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Two-tail P values for table 10 




GROUP LIVER KIDNEY HEART MUSCLE 
----------------------------------------------
1 vs 2 0,6457 0,5544 0,5262 0,0581 
1 vs 3 0,9215 0,8182 0,0486 0,0411 
2 vs 3 0,8696 0,6694 0,0233 0,1809 
Experiment 2 
GROUP LIVER KIDNEY HEART MUSCLE 
1 vs 2 0,0567 0,7507 0,289 0,2365 
1 vs 3 0,7726 0,4884 0,3091 0,5796 
2 vs 3 0,0603 0,1408 0,8174 0,3400 
A significant difference exists between groups 




1) PERCENTAGE OF Cu RECOVERED AFTER DIGESTION 
----------------------------------------------
ANIMAL LIVER KIDNEY HEART MUSCLE 
----------------------------------------------
1 100 113 95 96 
2 100 100 93 94 
3 100 108 93 92 
4 96 100 96 103 
5 94 90 92 93 
6 106 110 100 100 
7 94 90 107 94 
8 96 96 98 94 
9 91 98 92 97 
10 103 111 103 96 
11 107 106 97 95 
12 101 102 90 106 
2) PERCENTAGE OF Fe RECOVERED AFTER DIGESTION 
----------------------------------------------
ANIMAL LIVER KIDNEY HEART MUSCLE 
----------------------------------------------
1 99 90 98 91 
2 111 100 96 110 
3 92 93 99 97 
4 100 108 97 106 
5 98 99 100 91 
6 93 96 103 110 
7 112 104 106 113 
8 100 100 91 91 
9 98 103 95 95 
10 111 93 101 107 
11 110 110 108 111 




3) PERCENTAGE OF Zn RECOVER
ED AFTER DIGESTION 
-----------------------------------
-----------




1 91 113 
89 90 
2 93 91 
91 97 
3 90 97 
112 100 
4 103 109 
112 96 
5 90 110 
100 96 
6 94 102 
108 90 
7 112 106 
106 93 
8 100 90 
91 100 
9 96 89 
89 92 
10 91 100 
96 93 
11 92 93 
90 93 
12 96 94 
90 93 
-----------------------------------
-------
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